https://globalreachhealth.com/fda-advisory-panel-recommends-prescribing-naloxone-in-conjunction-with-opioids/2019-10-24T14:28:15+00:00https://globalreachhealth.com/ultomiris-approved/2025-01-23T18:34:46+00:00https://globalreachhealth.com/elzonris-receives-approval-to-treat-rare-blood-cancer/2025-01-23T18:34:59+00:00https://globalreachhealth.com/torrent-pharmaceuticals-recalls-losartan/2025-01-23T18:37:09+00:00https://globalreachhealth.com/updates-to-fluoroquinolone-safety-alert/2025-01-23T18:37:05+00:00https://globalreachhealth.com/new-guidance-on-acceptable-ndma-and-ndea/2025-01-23T18:36:58+00:00https://globalreachhealth.com/asparlas-approved-to-treat-acute-lymphoblastic-leukemia/2025-01-23T18:34:54+00:00https://globalreachhealth.com/keytruda-receives-new-indication-for-merkel-cell-carcinoma/2025-01-23T18:37:14+00:00https://globalreachhealth.com/lynparza-receives-new-indication/2025-01-23T18:37:07+00:00https://globalreachhealth.com/first-generic-for-canasa-approved/2019-10-24T15:57:25+00:00https://globalreachhealth.com/herzuma-approved-as-biosimilar-to-herceptin/2019-10-24T15:57:41+00:00https://globalreachhealth.com/nplate-receives-expanded-indication/2019-10-24T15:58:03+00:00https://globalreachhealth.com/motegrity-approved-to-treat-chronic-idiopathic-constipation/2019-10-24T15:58:23+00:00https://globalreachhealth.com/tolsura-approved-to-treat-fungal-infections/2019-10-24T15:58:40+00:00https://globalreachhealth.com/symjepi-to-launch-at-lower-cost-than-epipen-generic/2019-10-24T15:59:12+00:00https://globalreachhealth.com/tecentriq-receives-new-indication/2019-10-24T15:59:27+00:00https://globalreachhealth.com/tris-pharmaceuticals-recalls-infants-ibuprofen/2019-10-24T15:59:42+00:00https://globalreachhealth.com/dextenza-approved-to-treat-pain-following-ophthalmic-surgery/2019-10-24T15:59:57+00:00https://globalreachhealth.com/generics-to-become-available-for-epclusa-and-harvoni/2019-10-24T16:00:14+00:00https://globalreachhealth.com/idhifa-safety-alert-warns-of-differentiation-syndrome/2019-10-24T16:00:32+00:00https://globalreachhealth.com/fda-issues-lemtrada-safety-alert/2019-10-24T16:00:48+00:00https://globalreachhealth.com/firdapse-approved-to-treat-rare-autoimmune-disorder/2019-10-24T16:01:04+00:00https://globalreachhealth.com/xospata-approved-to-treat-acute-myeloid-leukemia/2019-10-24T16:01:20+00:00https://globalreachhealth.com/epipen-generics-launched/2019-10-24T16:01:38+00:00https://globalreachhealth.com/truxima-first-rituxan-biosimilar-approved/2019-10-24T16:01:54+00:00https://globalreachhealth.com/new-dosage-form-of-actemra-approved/2019-10-24T16:02:10+00:00https://globalreachhealth.com/temixys-approved-to-treat-hiv/2019-10-24T16:02:25+00:00https://globalreachhealth.com/brand-medications-with-generic-alternatives-anticipated-to-be-approved-in-january/2019-10-24T16:02:55+00:00https://globalreachhealth.com/ndma-identified-in-otc-and-prescription-ranitidine/2025-01-23T18:30:32+00:00https://globalreachhealth.com/rybelsus-approved-as-novel-treatment-for-diabetes/2025-01-23T18:30:54+00:00https://globalreachhealth.com/torrent-pharmaceuticals-expands-recall-of-losartan-products/2025-01-23T18:31:05+00:00https://globalreachhealth.com/new-indication-approved-for-pifeltro-and-delstrigo/2025-01-23T18:31:01+00:00https://globalreachhealth.com/erleada-receives-new-indication/2025-01-23T18:31:19+00:00https://globalreachhealth.com/keytruda-and-lenvima-approved-to-treat-endometrial-cancer/2025-01-23T18:31:13+00:00https://globalreachhealth.com/fda-issues-safety-communication-for-ibrance-kisqali-and-verzenio/2025-01-23T18:31:20+00:00https://globalreachhealth.com/nucala-receives-expanded-indication/2019-10-24T16:06:28+00:00https://globalreachhealth.com/ibsrela-approved-to-treat-irritable-bowel-syndrome/2025-01-23T18:32:55+00:00https://globalreachhealth.com/gvoke-approved-to-treat-hypoglycemia/2019-10-24T16:07:01+00:00https://globalreachhealth.com/aczone-gel-receives-expanded-approval/2019-10-24T16:07:14+00:00https://globalreachhealth.com/u-s-fda-stresses-importance-of-mmr-vaccination/2019-10-24T16:07:28+00:00https://globalreachhealth.com/ofev-granted-new-indication-to-treat-interstitial-lung-disease/2019-10-24T16:07:42+00:00https://globalreachhealth.com/natpara-recalled/2019-10-24T16:07:56+00:00https://globalreachhealth.com/authorized-generics-for-novolog-and-novolog-mix-announced/2019-10-24T16:08:10+00:00https://globalreachhealth.com/new-dosage-form-and-expanded-indications-for-harvoni/2019-10-24T16:08:25+00:00https://globalreachhealth.com/generic-amicar-approved/2019-10-24T16:08:40+00:00https://globalreachhealth.com/orfadin-generic-approved/2019-10-24T16:08:53+00:00https://globalreachhealth.com/noxafil-generic-launched/2019-10-24T16:09:07+00:00https://globalreachhealth.com/amex-pharmacy-voluntarily-recalls-bevacizumab/2019-10-24T16:09:28+00:00https://globalreachhealth.com/generic-for-alimta-receives-tentative-approval/2019-10-24T16:09:44+00:00https://globalreachhealth.com/fda-issues-safety-communication-regarding-use-of-hepatitis-c-drugs/2019-10-24T16:10:00+00:00https://globalreachhealth.com/nourianz-approved-to-treat-off-episodes-of-parkinsons-disease/2019-10-24T16:10:15+00:00https://globalreachhealth.com/taltz-receives-new-indication-for-ankylosing-spondylitis/2019-10-24T16:10:32+00:00https://globalreachhealth.com/myobloc-receives-new-indication/2019-10-24T16:10:46+00:00https://globalreachhealth.com/brand-medications-with-generic-alternatives-anticipated-to-be-approved-in-october/2019-10-24T16:11:06+00:00https://globalreachhealth.com/new-oral-film-form-of-riluzole-approved-to-treat-als/2020-01-14T07:16:56+00:00https://globalreachhealth.com/oxbryta-approved-to-treat-sickle-cell-disease/2020-01-14T07:24:07+00:00https://globalreachhealth.com/toujeo-receives-expanded-indication/2020-01-14T07:30:17+00:00https://globalreachhealth.com/new-injectable-form-of-methotrexate-approved/2020-01-14T07:37:41+00:00https://globalreachhealth.com/ogivri-launched-as-herceptin-biosimilar/2020-01-14T07:43:55+00:00https://globalreachhealth.com/new-lung-cancer-indication-for-tecentriq/2020-01-14T07:51:25+00:00https://globalreachhealth.com/first-generics-approved-for-ms-drug-gilenya/2020-01-14T07:56:30+00:00https://globalreachhealth.com/avsola-approved-as-remicade-biosimilar/2020-01-14T08:00:41+00:00https://globalreachhealth.com/jadenu-generics-available/2020-01-14T08:05:00+00:00https://globalreachhealth.com/first-afinitor-generic-launched/2020-01-14T08:08:39+00:00https://globalreachhealth.com/vyondys-53-approved-for-duchenne-muscular-dystrophy/2020-01-14T08:13:54+00:00https://globalreachhealth.com/xeljanz-xr-receives-new-indication-for-ulcerative-colitis/2020-01-14T08:19:30+00:00https://globalreachhealth.com/nuvaring-generic-approved-to-prevent-pregnancy/2020-01-14T08:23:43+00:00https://globalreachhealth.com/first-interoperable-automated-glycemic-controller-approved-for-use-with-insulin-pumps/2020-01-14T08:29:24+00:00https://globalreachhealth.com/vascepa-receives-new-indication-to-reduce-cardiovascular-risk/2020-01-14T08:33:45+00:00https://globalreachhealth.com/expanded-indication-approved-for-tiglutik/2020-01-14T08:37:10+00:00https://globalreachhealth.com/xtandi-receives-new-indication/2025-01-23T18:26:55+00:00https://globalreachhealth.com/glenmark-recalls-prescription-ranitidine/2025-01-23T18:25:48+00:00https://globalreachhealth.com/padcev-approved-to-treat-bladder-cancer/2025-01-23T18:24:41+00:00https://globalreachhealth.com/arazlo-approved-to-treat-acne/2025-01-23T18:24:35+00:00https://globalreachhealth.com/fda-safety-communication-for-gabapentin-and-pregabalin/2025-01-23T18:24:28+00:00https://globalreachhealth.com/first-ebola-vaccine-approved/2025-01-23T18:25:05+00:00https://globalreachhealth.com/lannett-company-voluntarily-recalls-seizure-medication/2025-01-23T18:25:45+00:00https://globalreachhealth.com/enhertu-approved-to-treat-breast-cancer/2025-01-23T18:23:36+00:00https://globalreachhealth.com/ubrelvy-approved-to-treat-migraines/2020-02-13T00:09:56+00:00https://globalreachhealth.com/caplyta-receives-approval-for-schizophrenia/2020-02-13T00:19:06+00:00https://globalreachhealth.com/dayvigo-approved-for-treatment-of-insomnia/2020-02-13T00:25:15+00:00https://globalreachhealth.com/conjupri-approved-for-hypertension/2020-02-13T00:29:14+00:00https://globalreachhealth.com/first-generics-for-eliquis-approved/2020-02-13T00:56:05+00:00https://globalreachhealth.com/mycamine-approved-for-new-indication/2020-02-13T00:59:49+00:00https://globalreachhealth.com/fiasp-indication-expanded-to-include-pediatric-patients/2020-02-13T01:04:01+00:00https://globalreachhealth.com/zilretta-receives-label-update/2020-02-13T01:09:12+00:00https://globalreachhealth.com/lynparza-receives-new-pancreatic-cancer-indication/2020-02-13T01:13:36+00:00https://globalreachhealth.com/aurobindo-voluntarily-recalls-one-lot-of-mirtazapine-tablets/2020-02-13T01:20:39+00:00https://globalreachhealth.com/avastin-biosimilar-zirabev-launched/2020-02-13T14:09:00+00:00https://globalreachhealth.com/nizatidine-and-ranitidine-products-recalled-due-to-ndma/2020-02-13T14:31:54+00:00https://globalreachhealth.com/keytruda-receives-new-bladder-cancer-indication/2020-02-13T14:37:22+00:00https://globalreachhealth.com/ayvakit-approved-as-first-targeted-therapy-for-gastrointestinal-tumors-with-rare-gene-mutation/2020-02-13T14:43:49+00:00https://globalreachhealth.com/taro-pharmaceuticals-recalls-one-lot-of-lamotrigine-tablets/2020-02-13T14:51:49+00:00https://globalreachhealth.com/valtoco-approved-to-treat-epilepsy/2020-02-13T15:00:31+00:00https://globalreachhealth.com/numbrino-approved-as-a-local-anesthetic/2025-01-23T18:21:23+00:00https://globalreachhealth.com/new-safety-warning-regarding-belviq-and-belviq-xr/2025-01-23T18:18:34+00:00https://globalreachhealth.com/eli-lilly-to-offer-lower-price-alternatives-for-two-additional-insulin-products/2025-01-23T18:18:28+00:00https://globalreachhealth.com/ozempic-receives-new-indication/2025-01-23T18:18:19+00:00https://globalreachhealth.com/rybelsus-label-update/2025-01-23T18:17:28+00:00https://globalreachhealth.com/monoferric-approved-to-treat-anemia/2025-01-23T18:17:17+00:00https://globalreachhealth.com/tepezza-first-drug-approved-to-treat-thyroid-eye-disease/2025-01-23T18:17:04+00:00https://globalreachhealth.com/tazverik-first-treatment-approved-specifically-for-epithelioid-sarcoma/2025-01-23T18:17:49+00:00https://globalreachhealth.com/some-latest-drug-news/2025-01-23T18:12:45+00:00https://globalreachhealth.com/answers-in-the-blood-convalescent-plasma-therapy-for-covid-19/2025-01-23T18:15:03+00:00https://globalreachhealth.com/fda-issues-safety-communication-for-xeljanz/2020-07-18T14:34:54+00:00https://globalreachhealth.com/accrufer-approved-to-treat-iron-deficiency/2020-07-18T15:09:07+00:00https://globalreachhealth.com/new-prostate-cancer-indication-for-lynparza/2020-09-28T12:10:03+00:00https://globalreachhealth.com/tecentriq-receives-new-lung-cancer-indication/2020-09-28T12:16:48+00:00https://globalreachhealth.com/opdivo-and-yervoy-approved-for-first-line-treatment-of-lung-cancer/2020-09-28T12:21:55+00:00https://globalreachhealth.com/rubraca-receives-new-indication/2020-09-28T12:26:48+00:00https://globalreachhealth.com/qinlock-approved-to-treat-gastrointestinal-stromal-tumors/2020-09-28T12:42:50+00:00https://globalreachhealth.com/pomalyst-receives-new-indication-for-kaposi-sarcoma/2020-09-28T12:47:38+00:00https://globalreachhealth.com/lynparza-receives-new-indication-for-ovarian-cancer/2020-09-28T12:52:42+00:00https://globalreachhealth.com/715-2/2020-09-28T12:58:50+00:00https://globalreachhealth.com/tabrecta-approved-for-lung-cancer/2020-09-28T13:02:19+00:00https://globalreachhealth.com/farxiga-receives-new-indication-for-heart-failure/2020-09-28T13:05:49+00:00https://globalreachhealth.com/fensolvi-approved-for-central-precocious-puberty/2020-09-28T13:12:17+00:00https://globalreachhealth.com/crysvita-receives-new-indication-to-treat-rare-bone-disease/2020-09-28T13:19:55+00:00https://globalreachhealth.com/keytruda-granted-new-indication-to-treat-cancer-based-on-biomarkers-regardless-of-tumor-type/2020-09-28T13:26:01+00:00https://globalreachhealth.com/mylotarg-receives-expanded-indication-for-leukemia/2020-09-28T13:30:00+00:00https://globalreachhealth.com/cosentyx-receives-new-indication-for-axial-spondyloarthritis/2020-09-28T13:36:04+00:00https://globalreachhealth.com/ilaris-receives-expanded-stills-disease-indication/2020-09-28T13:56:30+00:00https://globalreachhealth.com/u-s-fda-revokes-covid-19-emergency-use-authorization-forchloroquine-and-hydroxychloroquine/2020-09-28T14:04:12+00:00https://globalreachhealth.com/juvederm-voluma-xc-granted-new-cosmetic-indication/2020-09-28T14:08:26+00:00https://globalreachhealth.com/zepzelca-approved-to-treat-small-cell-lung-cancer/2020-09-28T14:16:00+00:00https://globalreachhealth.com/741-2/2020-09-28T14:33:11+00:00https://globalreachhealth.com/lyumjev-a-new-formulation-of-insulin-lispro-receives-approval/2020-09-28T14:52:01+00:00https://globalreachhealth.com/expanded-indication-and-new-dosage-form-for-tivicay/2020-09-28T14:55:50+00:00https://globalreachhealth.com/uplizna-approved-to-treat-rare-autoimmune-disorder/2020-09-28T14:59:45+00:00https://globalreachhealth.com/hydrochlorothiazide-receives-label-update/2025-01-23T18:09:15+00:00https://globalreachhealth.com/xeomin-receives-expanded-approval-for-upper-limb-spasticity/2025-01-23T18:09:35+00:00https://globalreachhealth.com/mylan-launches-newly-approved-tecfidera-generic/2025-01-23T18:09:17+00:00https://globalreachhealth.com/enspryng-approved-to-treat-rare-autoimmune-disorder/2025-01-23T18:09:40+00:00https://globalreachhealth.com/viltepso-approved-to-treat-duchenne-muscular-dystrophy/2025-01-23T18:09:43+00:00https://globalreachhealth.com/novel-opioid-olinvyk-approved-for-use-in-clinical-settings/2025-01-23T18:09:49+00:00https://globalreachhealth.com/evrysdi-approved-to-treat-spinal-muscular-atrophy/2025-01-23T18:10:49+00:00https://globalreachhealth.com/lampit-approved-to-treat-chagas-disease/2025-01-23T18:10:44+00:00https://globalreachhealth.com/dovato-receives-expanded-indication-for-hiv/2020-09-28T18:43:22+00:00https://globalreachhealth.com/blenrep-approved-as-first-in-new-class-of-cancer-treatment/2020-09-28T18:48:29+00:00https://globalreachhealth.com/spravato-receives-new-indication-to-treat-depression/2020-09-28T18:53:05+00:00https://globalreachhealth.com/monjuvi-approved-to-treat-diffuse-large-b-cell-lymphoma/2020-09-28T18:56:53+00:00https://globalreachhealth.com/prezcobix-hiv-indication-expanded-to-include-pediatric-patients/2020-09-28T19:00:26+00:00https://globalreachhealth.com/epidiolex-receives-new-indication-for-rare-genetic-disorder/2020-09-28T19:03:43+00:00https://globalreachhealth.com/evotaz-receives-expanded-indication-to-treat-hiv/2020-09-28T19:07:14+00:00https://globalreachhealth.com/stelara-receives-expanded-pediatric-plaque-psoriasis-indication/2020-09-28T19:10:33+00:00https://globalreachhealth.com/tecentriq-receives-new-melanoma-indication/2020-09-28T19:14:47+00:00https://globalreachhealth.com/fda-approves-first-generic-for-demser/2020-09-28T19:43:35+00:00https://globalreachhealth.com/xeglyze-approved-to-treat-head-lice/2020-09-28T19:24:30+00:00https://globalreachhealth.com/vectical-receives-expanded-plaque-psoriasis-indication/2020-09-28T19:28:15+00:00https://globalreachhealth.com/breztri-aerosphere-approved-as-triple-combination-maintenance-therapy-for-copd/2020-09-28T19:32:56+00:00https://globalreachhealth.com/updated-black-box-warning-for-benzodiazepines/2025-01-23T18:04:13+00:00https://globalreachhealth.com/sun-pharmaceuticals-voluntarily-recalls-one-lot-of-riomet-er/2025-01-23T18:04:11+00:00https://globalreachhealth.com/perrigo-voluntarily-recalls-albuterol-inhalers/2025-01-23T18:04:54+00:00https://globalreachhealth.com/fda-withdraws-approval-for-belviq-and-belviq-xr/2025-01-23T18:05:11+00:00https://globalreachhealth.com/acella-recalls-two-lots-of-np-thyroid/2025-01-23T18:05:02+00:00https://globalreachhealth.com/onureg-approved-to-treat-acute-myeloid-leukemia/2020-10-18T21:52:28+00:00https://globalreachhealth.com/trelegy-ellipta-receives-new-asthma-indication/2025-01-23T18:06:59+00:00https://globalreachhealth.com/new-tramadol-oral-solution-approved/2025-01-23T18:06:51+00:00https://globalreachhealth.com/gavreto-approved-to-treat-lung-cancer/2025-01-23T18:07:09+00:00https://globalreachhealth.com/minimed-770g-insulin-monitoring-and-delivery-system-approved/2020-10-18T22:09:15+00:00https://globalreachhealth.com/semglee-launched-as-alternative-to-lantus/2020-10-18T22:11:54+00:00https://globalreachhealth.com/xaracoll-approved-for-acute-pain-relief-following-hernia-repair/2020-10-18T22:48:28+00:00https://globalreachhealth.com/sogroya-approved-to-treat-growth-hormone-deficiency/2020-10-18T22:17:48+00:00https://globalreachhealth.com/fda-expands-emergency-use-authorization-for-remdesivir/2020-10-18T22:20:40+00:00https://globalreachhealth.com/ultravate-indication-expanded-to-include-pediatric-patients/2020-10-18T22:53:40+00:00https://globalreachhealth.com/winlevi-approved-to-treat-acne/2020-10-18T22:56:29+00:00https://globalreachhealth.com/fda-removes-black-box-warning-for-canagliflozin/2020-10-18T22:59:21+00:00https://globalreachhealth.com/nature-throid-and-wp-thyroid-recalled/2020-10-18T23:02:55+00:00https://globalreachhealth.com/new-proair-hfa-generic-approved/2020-10-18T23:05:23+00:00https://globalreachhealth.com/cystadrops-approved-to-treat-corneal-cystine-crystal-deposits/2020-10-18T23:07:43+00:00https://globalreachhealth.com/changes-to-mirena-indications/2020-10-18T23:09:57+00:00https://globalreachhealth.com/kyprolis-and-darzalex-receive-expanded-indications/2020-10-18T23:12:24+00:00https://globalreachhealth.com/bayshore-pharmaceuticals-recalls-two-lots-of-metformin-er/2020-10-18T23:17:15+00:00https://globalreachhealth.com/kesimpta-approved-to-treat-relapsing-multiple-sclerosis/2020-10-18T23:20:09+00:00https://globalreachhealth.com/remdesivir-approved-to-treat-covid-19/2025-01-23T17:58:46+00:00https://globalreachhealth.com/fda-generic-drug-approvals-down-in-2020/2025-01-23T18:01:09+00:00https://globalreachhealth.com/keytruda-receives-new-hodgkin-lymphoma-indication/2025-01-23T17:58:55+00:00https://globalreachhealth.com/wakix-receives-expanded-indication/2020-12-07T03:26:32+00:00https://globalreachhealth.com/inmazeb-approved-to-treat-ebola/2020-12-07T03:29:48+00:00https://globalreachhealth.com/fda-emphasizes-proper-insulin-pen-dispensing/2020-12-07T03:34:01+00:00https://globalreachhealth.com/makena-market-withdrawal-proposed/2020-12-07T03:37:46+00:00https://globalreachhealth.com/teva-launches-truvada-and-atripla-generics/2020-12-07T03:40:47+00:00https://globalreachhealth.com/opdivo-and-yervoy-approved-for-mesothelioma/2020-12-07T04:25:49+00:00https://globalreachhealth.com/marksans-expands-metformin-er-recall/2020-12-07T04:30:55+00:00https://globalreachhealth.com/tykerb-generic-launched/2020-12-07T04:35:07+00:00https://globalreachhealth.com/alkindi-sprinkle-approved-for-pediatric-hormone-disorder/2020-12-07T04:39:20+00:00https://globalreachhealth.com/simponi-aria-granted-new-and-expanded-arthritis-indications/2020-12-07T04:43:38+00:00https://globalreachhealth.com/xeljanz-receives-new-pediatric-indication/2020-12-07T04:46:23+00:00https://globalreachhealth.com/haegarda-receives-expanded-indication-for-hereditary-angioedema/2020-12-07T04:49:17+00:00https://globalreachhealth.com/kalydeco-receives-expanded-indication-for-pediatric-patients/2020-12-07T04:52:05+00:00https://globalreachhealth.com/fetroja-receives-new-indication-for-pneumonia/2020-12-07T04:55:32+00:00https://globalreachhealth.com/nucala-receives-new-indication-for-rare-blood-disorder/2020-12-07T04:58:38+00:00https://globalreachhealth.com/eraxis-indication-expanded-to-include-pediatric-patients/2020-12-07T05:01:54+00:00https://globalreachhealth.com/emergency-use-authorization-pfizer-and-biontech-covid-19-vaccine/2025-01-23T17:58:14+00:00https://globalreachhealth.com/new-indication-for-kineret-to-treat-ultra-rare-genetic-disorder/2021-01-25T17:05:44+00:00https://globalreachhealth.com/arcalyst-receives-new-indication-for-rare-inflammatory-disorder/2021-01-25T17:23:08+00:00https://globalreachhealth.com/xeomin-receives-expanded-indication/2021-01-25T17:32:58+00:00https://globalreachhealth.com/ebanga-becomes-second-fda-approved-ebola-drug/2021-01-25T17:39:39+00:00https://globalreachhealth.com/emergency-use-authorization-granted-to-modernas-covid-19-vaccine/2021-01-25T17:47:20+00:00https://globalreachhealth.com/xpovio-granted-new-multiple-myeloma-indication/2021-01-25T17:52:15+00:00https://globalreachhealth.com/tagrisso-receives-new-indication-for-lung-cancer/2021-01-25T18:02:26+00:00https://globalreachhealth.com/orgovyx-approved-for-advanced-prostate-cancer/2021-01-25T18:09:22+00:00https://globalreachhealth.com/third-biosimilar-for-rituxan-approved/2021-01-25T18:14:57+00:00https://globalreachhealth.com/margenza-approved-to-treat-metastatic-her2-breast-cancer/2021-01-25T18:22:24+00:00https://globalreachhealth.com/hydroxyzine-hydrochloride-syrup-recalled/2021-01-26T03:54:12+00:00https://globalreachhealth.com/klisyri-approved-to-treat-actinic-keratosis/2021-01-25T18:39:10+00:00https://globalreachhealth.com/pfizer-covid-19-vaccine-receives-emergency-use-authorization/2021-01-26T03:41:32+00:00https://globalreachhealth.com/shorter-infusion-time-approved-for-ocrevus/2021-01-25T18:49:50+00:00https://globalreachhealth.com/thyquidity-approved-for-thyroid-hormone-replacement-therapy/2021-01-25T18:55:12+00:00https://globalreachhealth.com/torrent-pharmaceuticals-issues-anagrelide-recall/2021-01-25T19:03:13+00:00https://globalreachhealth.com/avkare-recalls-sildenafil-and-trazodone/2021-01-25T19:08:08+00:00https://globalreachhealth.com/saxenda-receives-expanded-approval-for-weight-management/2021-01-25T19:14:33+00:00https://globalreachhealth.com/label-update-required-for-diabetes-drugs-containing-sitagliptin/2021-01-25T19:34:01+00:00https://globalreachhealth.com/orladeyo-approved-to-prevent-hae-attacks/2021-01-25T19:49:54+00:00https://globalreachhealth.com/hetlioz-receives-new-indication-for-rare-genetic-disorder/2021-01-25T20:05:11+00:00https://globalreachhealth.com/xolair-receives-new-indication-to-treat-nasal-polyps/2021-01-25T20:11:13+00:00https://globalreachhealth.com/gavreto-receives-new-thyroid-cancer-indications/2021-01-25T20:17:30+00:00https://globalreachhealth.com/fda-approves-new-pet-imaging-drug-for-prostate-cancer/2021-01-25T20:22:35+00:00https://globalreachhealth.com/imcivree-approved-to-treat-rare-genetic-conditions-that-cause-severe-obesity/2021-01-26T02:22:56+00:00https://globalreachhealth.com/danyelza-approved-to-treat-neuroblastoma/2021-01-26T02:27:08+00:00https://globalreachhealth.com/oxlumo-approved-to-treat-rare-metabolic-disorder/2021-01-26T02:30:19+00:00https://globalreachhealth.com/brand-medications-with-generic-alternatives-anticipated-to-be-approved-in-january-2/2024-04-22T17:55:09+00:00https://globalreachhealth.com/covid19-vaccines-and-other-regulatory-highlights/2024-04-22T17:54:53+00:00https://globalreachhealth.com/an-informed-approach-to-new-to-market-drugs-protecting-members/2024-04-22T17:54:04+00:00https://globalreachhealth.com/lupkynis-approved-as-first-oral-therapy-for-lupus-nephritis/2024-04-22T17:54:15+00:00https://globalreachhealth.com/cabenuva-approved-as-once-monthly-complete-hiv-treatment-regimen/2021-02-18T02:11:15+00:00https://globalreachhealth.com/verquvo-approved-for-heart-failure/2021-02-18T02:16:26+00:00https://globalreachhealth.com/enhertu-approved-for-new-gastric-cancer-indication/2021-02-18T02:19:38+00:00https://globalreachhealth.com/darzalex-faspro-receives-new-indication-for-rare-disorder/2021-02-18T02:27:39+00:00https://globalreachhealth.com/xalkori-granted-new-lymphoma-indication/2021-02-18T02:30:12+00:00https://globalreachhealth.com/fresenius-kabi-recalls-one-lot-of-ketorolac-tromethamine-injection/2021-02-18T02:33:53+00:00https://globalreachhealth.com/fda-approves-near-record-number-of-new-drugs-in-2020/2021-02-18T02:36:42+00:00https://globalreachhealth.com/kala-pharmaceuticals-launches-dry-eye-treatment-eysuvis/2021-02-18T02:39:07+00:00https://globalreachhealth.com/production-of-catapres-for-hypertension-discontinued/2021-02-18T02:41:23+00:00https://globalreachhealth.com/authorized-generic-for-amitiza-approved/2021-02-18T02:43:51+00:00https://globalreachhealth.com/nostrum-laboratories-includes-additional-lot-in-metformin-recall/2021-02-18T02:46:31+00:00https://globalreachhealth.com/chlorhexidine-gluconate-oral-rinse-recall-expanded/2021-02-18T02:51:52+00:00https://globalreachhealth.com/first-generic-of-glucagon-for-injection-approved/2021-02-18T02:54:36+00:00https://globalreachhealth.com/1024-2/2021-02-18T02:58:00+00:00https://globalreachhealth.com/vaxchora-indication-expanded-to-include-children/2021-02-18T03:01:41+00:00https://globalreachhealth.com/indications-expanded-for-three-cystic-fibrosis-drugs/2021-02-18T03:04:45+00:00https://globalreachhealth.com/automatic-refills-are-they-really-that-great/2024-04-22T17:54:09+00:00https://globalreachhealth.com/anatomy-of-a-drug-recall/2024-04-22T17:53:05+00:00https://globalreachhealth.com/important-updates-regarding-additional-populations-eligible-to-receive-covid-19-vaccines/2024-04-22T17:52:59+00:00https://globalreachhealth.com/covid-19-oxygen-emergency-impacting-more-than-half-a-million-people-in-low-and-middle-income-countries-every-day-as-demand-surges/2024-04-22T17:53:10+00:00https://globalreachhealth.com/johnson-johnson-announces-advance-purchase-agreement-with-the-african-vaccine-acquisition-trust-for-the-companys-covid-19-vaccine-candidate/2024-04-22T17:47:46+00:00https://globalreachhealth.com/meet-the-doctors/2021-04-07T18:09:57+00:00https://globalreachhealth.com/donation-drive-for-guatemala/2021-04-07T21:02:19+00:00https://globalreachhealth.com/donation-drive-guatemala/2021-05-18T08:50:27+00:00https://globalreachhealth.com/important-updates-for-health-care-providers-regarding-johnson-johnsons-janssen-covid-19-vaccine/2024-04-22T17:40:26+00:00https://globalreachhealth.com/keytruda-receives-new-esophageal-cancer-indication/2024-04-22T17:49:20+00:00https://globalreachhealth.com/zegalogue-approved-to-treat-severe-hypoglycemia/2024-04-22T17:49:13+00:00https://globalreachhealth.com/ponvory-approved-to-treat-multiple-sclerosis/2024-04-22T17:50:16+00:00https://globalreachhealth.com/arcalyst-receives-new-indication-for-inflammation-of-the-pericardium/2024-04-22T17:51:36+00:00https://globalreachhealth.com/fda-updates-fact-sheets-for-monoclonal-antibodies-used-to-treat-covid-19/2024-04-22T17:51:30+00:00https://globalreachhealth.com/kimyrsa-approved-to-treat-bacterial-skin-and-skin-structure-infections/2024-04-22T17:51:24+00:00https://globalreachhealth.com/fabrazyme-receives-expanded-indication-for-fabry-disease/2024-04-22T17:51:17+00:00https://globalreachhealth.com/sagent-pharmaceuticals-recalls-phenylephrine-hcl-injection/2024-04-22T17:50:54+00:00https://globalreachhealth.com/fotivda-approved-to-treat-renal-cell-carcinoma/2024-04-22T17:51:07+00:00https://globalreachhealth.com/bryant-ranch-prepack-recalls-spironolactone-tablets/2024-04-22T17:52:53+00:00https://globalreachhealth.com/fda-grants-tentative-approval-for-symbicort-generic/2021-04-21T10:11:52+00:00https://globalreachhealth.com/tecentriq-no-longer-indicated-for-prior-platinum-treated-metastatic-urothelial-carcinoma/2021-04-21T10:14:15+00:00https://globalreachhealth.com/yescarta-receives-follicular-lymphoma-indication/2021-04-21T10:17:14+00:00https://globalreachhealth.com/flucelvax-quadrivalent-receives-expanded-flu-indication/2021-04-21T10:19:58+00:00https://globalreachhealth.com/actemra-receives-new-indication-to-treat-interstitial-lung-disease-in-patients-diagnosed-with-systemic-sclerosis/2021-04-21T10:23:21+00:00https://globalreachhealth.com/lorbrena-gains-full-fda-approval-expanded-lung-cancer-indication/2021-04-21T10:26:05+00:00https://globalreachhealth.com/azstarys-approved-to-treat-adhd/2021-04-21T10:29:32+00:00https://globalreachhealth.com/small-cell-lung-cancer-indications-withdrawn-for-keytruda-opdivo/2021-04-21T10:32:10+00:00https://globalreachhealth.com/nulibry-approved-to-treat-rare-genetic-disorder/2021-04-21T10:35:03+00:00https://globalreachhealth.com/emergency-use-authorization-granted-for-johnson-johnsons-covid-19-vaccine/2021-04-21T10:38:08+00:00https://globalreachhealth.com/pepaxto-approved-to-treat-multiple-myeloma/2021-04-21T10:40:59+00:00https://globalreachhealth.com/updates-to-storage-requirements-for-pfizer-covid-19-vaccine/2021-04-21T10:44:48+00:00https://globalreachhealth.com/amondys-45-approved-to-treat-duchenne-muscular-dystrophy/2021-04-21T10:47:46+00:00https://globalreachhealth.com/humira-ulcerative-colitis-indication-expanded-to-include-children/2021-04-21T10:50:41+00:00https://globalreachhealth.com/libtayo-receives-new-lung-cancer-indication/2021-04-21T10:53:05+00:00https://globalreachhealth.com/astrazeneca-withdraws-imfinzi-bladder-cancer-indication/2021-04-21T10:55:22+00:00https://globalreachhealth.com/fda-partially-rescinds-approvals-for-two-hemophilia-b-treatments/2021-04-21T10:58:42+00:00https://globalreachhealth.com/brand-medications-with-generic-alternatives-anticipated-to-be-approved-in-april/2024-04-22T17:47:52+00:00https://globalreachhealth.com/primary-formulary-changes/2021-09-29T00:15:31+00:00https://globalreachhealth.com/johnson-johnson-covid-19-vaccine-distribution-resumes/2024-04-22T17:36:36+00:00https://globalreachhealth.com/ragwitek-approval-expanded-to-include-pediatric-use/2024-04-22T17:42:42+00:00https://globalreachhealth.com/new-opdivo-indication-approved-for-gastrointestinal-cancers/2024-04-22T17:41:07+00:00https://globalreachhealth.com/fda-rescinds-emergency-use-authorization-for-solo-use-of-investigational-covid-19-drug/2024-04-22T17:42:19+00:00https://globalreachhealth.com/nextstellis-approved-as-a-contraceptive/2024-04-22T17:41:43+00:00https://globalreachhealth.com/trodelvy-receives-accelerated-approval-for-urothelial-cancer/2024-04-22T17:46:09+00:00https://globalreachhealth.com/trodelvy-granted-full-approval-for-triple-negative-breast-cancer/2024-04-22T17:47:07+00:00https://globalreachhealth.com/new-dosing-regimen-approved-for-erbitux/2021-05-18T06:15:04+00:00https://globalreachhealth.com/qelbree-becomes-first-non-stimulant-adhd-medication-approved-in-over-a-decade/2021-05-18T06:19:26+00:00https://globalreachhealth.com/acetaminophen-in-health-essentials-kits-recalled-due-to-mislabeling/2021-05-18T06:26:49+00:00https://globalreachhealth.com/u-s-fda-updates-storage-guidelines-for-moderna-covid-19-vaccine/2021-05-18T06:44:58+00:00https://globalreachhealth.com/praluent-granted-new-indication-for-rare-form-of-high-cholesterol/2021-05-18T06:48:31+00:00https://globalreachhealth.com/tyvaso-receives-new-indication-for-patients-who-have-interstitial-lung-disease/2021-05-18T06:51:18+00:00https://globalreachhealth.com/sarclisa-receives-new-indication-for-relapsed-or-refractory-multiple-myeloma/2021-05-18T06:57:58+00:00https://globalreachhealth.com/lamotrigine-associated-with-potential-for-irregular-heartbeat/2021-05-18T07:01:31+00:00https://globalreachhealth.com/vyxeos-cancer-indication-expanded-to-include-children/2021-05-18T07:04:34+00:00https://globalreachhealth.com/myrbetriq-receives-new-pediatric-indication/2021-05-18T07:08:11+00:00https://globalreachhealth.com/abecma-approved-to-treat-multiple-myeloma/2021-05-18T07:11:18+00:00https://globalreachhealth.com/zydus-pharmaceuticals-recalls-four-lots-of-acyclovir-sodium-injection/2021-05-18T07:14:44+00:00https://globalreachhealth.com/shingrix-label-updated-due-to-risk-of-rare-autoimmune-syndrome/2021-05-18T07:17:29+00:00https://globalreachhealth.com/fda-issues-safety-alert-for-over-the-counter-decongestant/2021-05-18T07:21:11+00:00https://globalreachhealth.com/alembic-pharmaceuticals-recalls-one-lot-of-telmisartan-tablets/2021-05-18T07:25:29+00:00https://globalreachhealth.com/exparel-receives-pediatric-indication-for-post-surgical-pain-relief/2021-05-18T07:29:15+00:00https://globalreachhealth.com/pfizer-biontech-vaccine-receives-expanded-eua-updated-storage-guidelines/2021-09-28T22:42:17+00:00https://globalreachhealth.com/empaveli-approved-to-treat-rare-blood-disorder/2021-09-28T22:40:28+00:00https://globalreachhealth.com/zynrelef-approved-for-non-opioid-pain-relief-after-surgery/2021-09-28T22:41:10+00:00https://globalreachhealth.com/novonordisk-recalls-samples-of-insulin-products/2021-09-28T23:54:21+00:00https://globalreachhealth.com/new-single-dose-option-approved-for-injectafer/2021-09-28T23:16:43+00:00https://globalreachhealth.com/keytruda-granted-new-gastric-cancer-indication/2021-09-28T23:55:17+00:00https://globalreachhealth.com/hospira-recalls-select-lots-of-bupivacaine-and-lidocaine/2021-09-28T23:24:55+00:00https://globalreachhealth.com/ferriprox-receives-new-and-expanded-indications/2021-09-28T23:28:37+00:00https://globalreachhealth.com/farxiga-receives-new-indication-to-treat-kidney-disease/2021-09-28T23:33:15+00:00https://globalreachhealth.com/np-thyroid-recalled-due-to-subpotency/2021-09-28T23:48:11+00:00https://globalreachhealth.com/higher-dose-of-naloxone-approved-for-overdose-treatment/2021-09-28T23:56:35+00:00https://globalreachhealth.com/natroba-approved-to-treat-scabies-infestations/2021-09-29T00:01:06+00:00https://globalreachhealth.com/zynlonta-approved-to-treat-large-b-cell-lymphoma/2021-09-29T00:04:24+00:00https://globalreachhealth.com/jemperli-receives-accelerated-approval-for-endometrial-cancer/2021-09-29T00:07:49+00:00https://globalreachhealth.com/diovan-receives-expanded-approval/2021-09-29T00:10:47+00:00https://globalreachhealth.com/evekeo-odt-adhd-indication-expanded/2021-09-29T00:14:20+00:00https://globalreachhealth.com/stratagraft-approved-to-treat-thermal-burns/2021-09-29T00:46:59+00:00https://globalreachhealth.com/epclusa-and-mavyret-granted-expanded-hepatitis-c-indications/2021-09-29T00:53:45+00:00https://globalreachhealth.com/two-lots-of-metformin-recalled-due-to-ndma/2021-09-29T00:57:03+00:00https://globalreachhealth.com/longer-shelf-life-authorized-for-johnson-johnson-covid-19-vaccine/2021-09-29T00:59:50+00:00https://globalreachhealth.com/trikafta-receives-expanded-cystic-fibrosis-approval/2021-09-29T01:03:38+00:00https://globalreachhealth.com/prevnar-20-approved-to-prevent-pneumococcal-disease/2021-09-29T01:28:57+00:00https://globalreachhealth.com/ryplazim-approved-to-treat-rare-genetic-disorder/2021-09-29T01:32:21+00:00https://globalreachhealth.com/aduhelm-becomes-first-new-fda-approved-alzheimers-therapy-since-2003/2021-09-29T01:38:03+00:00https://globalreachhealth.com/rare-blood-disorder-indication-for-ultomiris-expanded-to-include-pediatric-patients/2021-09-29T01:41:51+00:00https://globalreachhealth.com/black-box-warning-added-to-anthrax-medication/2021-09-29T01:45:05+00:00https://globalreachhealth.com/tembexa-approved-to-treat-smallpox/2021-09-29T01:48:46+00:00https://globalreachhealth.com/wegovy-approved-for-chronic-weight-management/2021-09-29T01:52:17+00:00https://globalreachhealth.com/lower-dose-new-route-of-administrationauthorized-for-regen-cov-covid-19-treatment/2021-09-29T01:56:25+00:00https://globalreachhealth.com/noxafil-receives-expanded-indication-and-new-dosage-form/2021-09-29T02:02:38+00:00https://globalreachhealth.com/fda-approves-first-novel-antifungal-treatment-for-yeast-infections-in-over-20-years/2021-09-29T02:06:38+00:00https://globalreachhealth.com/truseltiq-approved-to-treat-aggressive-bile-duct-cancer/2021-09-29T02:10:25+00:00https://globalreachhealth.com/lybalvi-approved-to-treat-schizophrenia-and-bipolar-i-disorder/2021-09-29T02:16:31+00:00https://globalreachhealth.com/cosentyx-receives-expanded-plaque-psoriasis-indication/2021-09-29T02:19:40+00:00https://globalreachhealth.com/lumakras-approved-as-first-targeted-therapy-for-drug-resistant-kras-g12c-lung-cancer-mutation/2021-09-29T02:24:10+00:00https://globalreachhealth.com/zipsor-indication-expanded-to-include-adolescent-patients/2021-09-29T02:27:16+00:00https://globalreachhealth.com/nurtec-odt-granted-indication-to-prevent-episodic-migraines/2021-09-29T02:31:10+00:00https://globalreachhealth.com/zeposia-becomes-first-in-class-treatment-for-ulcerative-colitis/2021-09-29T04:37:05+00:00https://globalreachhealth.com/yervoy-receives-expanded-melanoma-indication-for-adults/2021-09-29T04:41:20+00:00https://globalreachhealth.com/pylarify-approved-for-pet-imaging-of-prostate-cancer/2021-09-29T04:45:51+00:00https://globalreachhealth.com/camcevi-approved-to-treat-prostate-cancer/2021-09-29T04:49:27+00:00https://globalreachhealth.com/myfembree-approved-to-manage-heavy-menstrual-bleeding-due-to-uterine-fibroids/2021-09-29T04:53:50+00:00https://globalreachhealth.com/fda-restricts-use-of-ocaliva-in-some-patients/2021-09-29T04:57:33+00:00https://globalreachhealth.com/investigational-drug-sotrovimab-granted-emergency-use-authorization-for-outpatient-treatment-of-covid-19/2021-09-29T05:22:10+00:00https://globalreachhealth.com/rybrevant-receives-accelerated-approval-to-treat-lung-cancer/2021-09-29T05:21:05+00:00https://globalreachhealth.com/opdivo-receives-new-indication-for-esophageal-and-gastroesophageal-junction-cancer/2021-09-29T05:11:20+00:00https://globalreachhealth.com/kedrab-approval-expanded-to-prevent-rabies-in-children/2021-09-29T05:14:30+00:00https://globalreachhealth.com/first-fda-approved-medication-for-rare-liver-disorder-launched/2021-09-29T11:54:19+00:00https://globalreachhealth.com/fda-requests-removal-of-warning-against-statin-use-in-pregnant-individuals/2021-09-29T11:59:08+00:00https://globalreachhealth.com/amidst-chantix-recall-fda-allowsimport-of-canadian-therapeutic-alternative/2021-09-29T16:17:43+00:00https://globalreachhealth.com/new-oral-treatment-for-sleeping-sickness-approved/2021-09-29T12:09:41+00:00https://globalreachhealth.com/vaxneuvance-approved-to-prevent-pneumococcal-disease/2021-09-29T12:40:25+00:00https://globalreachhealth.com/fda-approves-first-in-class-treatment-for-chronic-graft-versus-host-disease/2021-09-29T12:44:44+00:00https://globalreachhealth.com/prograf-becomes-first-fda-approved-drug-to-prevent-organ-rejection-in-adult-and-pediatric-lung-transplant-recipients/2021-09-29T12:49:17+00:00https://globalreachhealth.com/darzalex-faspro-receives-new-multiple-myeloma-indication/2021-09-29T12:53:54+00:00https://globalreachhealth.com/fda-requires-expanded-black-box-warning-for-hydroxyethyl-starch-products-used-to-treat-and-prevent-hypovolemia/2021-09-29T12:56:59+00:00https://globalreachhealth.com/padcev-receives-full-approval-andnew-indication-to-treat-urothelial-cancer/2021-09-29T13:03:44+00:00https://globalreachhealth.com/kerendia-approved-to-treat-chronic-kidney-disease-associated-with-type-2-diabetes/2021-09-29T13:25:19+00:00https://globalreachhealth.com/bridion-indication-expanded-to-include-pediatric-patients/2021-09-29T13:29:02+00:00https://globalreachhealth.com/armonair-respiclick-now-indicated-for-broader-pediatric-use/2021-09-29T13:32:59+00:00https://globalreachhealth.com/noxafil-receives-new-indication-for-potentially-fatal-mold-infection/2021-09-29T13:45:45+00:00https://globalreachhealth.com/solosec-receives-new-indication-to-treat-common-sexually-transmitted-infection/2021-09-29T13:51:34+00:00https://globalreachhealth.com/merck-announces-plan-to-withdraw-keytrudas-monotherapy-indication-for-pd-l1-positive-gastric-and-gej-cancer/2021-09-29T13:56:02+00:00https://globalreachhealth.com/teva-recalls-topotecan-injection-to-retail-institutional-level/2021-09-29T14:01:24+00:00https://globalreachhealth.com/rylaze-approved-to-treat-all-and-lbl-in-patients-allergic-to-e-coli-derived-chemotherapy-component/2021-09-29T14:06:27+00:00https://globalreachhealth.com/restylane-contour-approved-for-cheek-augmentation-and-correction-of-midface-contour-deficiencies-in-adults/2021-09-29T14:11:15+00:00https://globalreachhealth.com/heart-inflammation-warning-added-to-eua-fact-sheets-for-pfizer-biontech-and-moderna-covid-19-vaccines/2021-09-29T14:15:17+00:00https://globalreachhealth.com/actemra-receives-emergency-use-authorization-to-treat-covid-19/2021-09-29T14:24:02+00:00https://globalreachhealth.com/toviaz-receives-new-indication-to-treatneurogenic-detrusor-overactivity-in-children/2021-09-29T15:26:16+00:00https://globalreachhealth.com/ayvakit-receives-new-indication-for-rare-mast-cell-disorders/2021-09-29T15:31:52+00:00https://globalreachhealth.com/pradaxa-becomes-first-fda-approved-oral-blood-thinner-for-children/2021-09-29T15:35:51+00:00https://globalreachhealth.com/smiths-medical-issues-class-i-recall-of-insulin-syringes/2021-09-29T15:48:23+00:00https://globalreachhealth.com/astepro-allergy-approved-under-partial-rx-to-otc-switch/2021-09-29T15:53:15+00:00https://globalreachhealth.com/rezipres-approved-to-treat-hypotension-in-patients-under-anesthesia/2021-09-29T15:57:27+00:00https://globalreachhealth.com/jardiance-receives-new-heart-failure-indication/2025-01-23T15:21:05+00:00https://globalreachhealth.com/jemperli-receives-accelerated-approval-to-treat-solid-tumors/2025-01-23T15:21:40+00:00https://globalreachhealth.com/welireg-approved-for-genetic-condition-tied-to-tumor-growth/2025-01-23T17:48:34+00:00https://globalreachhealth.com/pfizer-adds-four-lots-to-chantix-recall/2025-01-23T15:22:08+00:00https://globalreachhealth.com/ticovac-wins-u-s-fda-approval-to-prevent-tick-borne-encephalitis/2025-01-23T17:48:24+00:00https://globalreachhealth.com/mirena-receives-expanded-approval-for-contraception/2025-01-23T17:48:44+00:00https://globalreachhealth.com/moderna-pfizer-biontech-covid-19-vaccines-authorized-for-use-as-booster-shots-for-immunocompromised-individuals/2021-09-29T20:03:48+00:00https://globalreachhealth.com/durezol-generic-launched-approved-to-treat-eye-inflammation/2025-01-23T17:49:22+00:00https://globalreachhealth.com/fda-grants-first-drug-approval-for-uncommon-sleep-disorder/2025-01-23T17:49:12+00:00https://globalreachhealth.com/sodium-bicarbonate-for-injection-recalled-to-hospital-pharmacy-level/2021-09-29T20:16:01+00:00https://globalreachhealth.com/new-enzyme-replacement-therapy-approved-for-pompe-disease/2021-09-29T20:19:32+00:00https://globalreachhealth.com/two-lots-of-atovaquone-oral-suspension-recalled/2021-09-30T02:07:54+00:00https://globalreachhealth.com/saphnelo-approved-as-first-in-class-treatment-for-lupus/2021-09-30T02:12:52+00:00https://globalreachhealth.com/1440-2/2021-09-30T02:17:28+00:00https://globalreachhealth.com/nucala-receives-new-nasal-polyps-indication/2021-09-30T02:21:35+00:00https://globalreachhealth.com/changes-made-to-risk-evaluation-and-mitigation-strategy-for-drug-approved-to-treat-schizophrenia/2021-09-30T02:25:46+00:00https://globalreachhealth.com/keytruda-receives-two-new-indications-bringing-total-number-to-30/2021-09-30T02:29:35+00:00https://globalreachhealth.com/fda-makes-semglee-the-first-interchangeable-biosimilar/2021-09-30T02:33:38+00:00https://globalreachhealth.com/olumiant-authorized-for-use-alone-to-treat-covid-19-in-hospitalized-patients/2021-09-30T02:36:46+00:00https://globalreachhealth.com/pepaxto-associated-with-increased-risk-of-death-in-a-clinical-trial/2021-09-30T02:40:27+00:00https://globalreachhealth.com/first-fixed-dose-combination-of-tretinoin-and-benzoyl-peroxide-receives-fda-approval-to-treat-acne/2021-09-30T02:44:07+00:00https://globalreachhealth.com/shingrix-approval-expanded-to-include-immunocompromised-adults-under-the-age-of-50/2021-09-30T02:48:04+00:00https://globalreachhealth.com/drizalma-sprinkle-receives-new-indication-for-fibromyalgia/2021-09-30T02:51:06+00:00https://globalreachhealth.com/opdivo-loses-indication-as-single-agent-treatment-for-liver-cancer/2021-09-30T02:54:16+00:00https://globalreachhealth.com/bydureon-bcise-now-indicated-to-treat-type-2-diabetes-in-children/2021-09-30T02:58:09+00:00https://globalreachhealth.com/dalvance-now-indicated-to-treat-acute-bacterial-skin-and-skin-structure-infections-in-children-as-well-as-adults/2021-09-30T03:00:31+00:00https://globalreachhealth.com/octagam-receives-indication-for-rare-disease-of-the-muscle-tissues/2021-09-30T03:04:20+00:00https://globalreachhealth.com/fda-approves-ophthalmic-biosimilar-byooviz/2025-01-23T14:58:19+00:00https://globalreachhealth.com/new-lung-cancer-drug-exkivity-receives-fda-approval/2025-01-23T14:57:55+00:00https://globalreachhealth.com/fda-approves-new-long-acting-schizophrenia-treatment/2021-10-12T23:15:03+00:00https://globalreachhealth.com/skytrofa-approved-for-pediatric-growth-hormone-deficiency/2021-10-12T23:19:33+00:00https://globalreachhealth.com/korsuva-becomes-first-in-a-new-class-of-drugs-to-win-fda-approval/2021-10-12T23:23:55+00:00https://globalreachhealth.com/pfizer-biontechs-covid-19-vaccine-granted-full-fda-approval/2021-10-12T23:29:51+00:00https://globalreachhealth.com/cabometyx-now-indicated-to-treat-common-form-of-thyroid-cancer/2025-01-23T15:13:54+00:00https://globalreachhealth.com/two-drug-therapy-authorized-for-covid-19-post-exposure-prevention/2025-01-23T15:14:18+00:00https://globalreachhealth.com/brukinsa-receives-two-new-lymphoma-indications/2025-01-23T15:06:03+00:00https://globalreachhealth.com/keytruda-granted-full-approval-for-urothelial-carcinoma-indication/2021-10-13T02:08:05+00:00https://globalreachhealth.com/expanded-indication-for-briviact-in-seizure-treatment/2021-10-13T02:21:10+00:00https://globalreachhealth.com/use-of-bamlanivimab-and-etesevimab-to-treat-covid-19-resumes/2021-10-13T02:19:39+00:00https://globalreachhealth.com/tibsovo-becomes-a-new-treatment-option-for-rare-bile-duct-cancer/2021-10-13T02:26:10+00:00https://globalreachhealth.com/xarelto-receives-expanded-indication-for-peripheral-artery-disease/2021-10-13T02:32:19+00:00https://globalreachhealth.com/opdivo-granted-new-indication-for-urothelial-carcinoma/2021-10-13T02:35:33+00:00https://globalreachhealth.com/pfizer-expands-chantix-recall-to-include-all-0-5mg-and-1mg-tablets/2025-01-23T15:05:18+00:00https://globalreachhealth.com/three-lots-of-ruzurgi-recalled-due-to-contamination/2025-01-23T15:15:33+00:00https://globalreachhealth.com/one-lot-of-firvanq-recalled-after-being-packaged-with-wrong-diluent/2025-01-23T15:13:22+00:00https://globalreachhealth.com/icu-medical-recalls-aminosyn-ii-because-of-particulate-matter/2021-10-13T20:05:49+00:00https://globalreachhealth.com/topical-lidocaine-solution-recalled-due-to-superpotency/2021-10-13T20:10:56+00:00https://globalreachhealth.com/fda-requires-new-warnings-on-drugs-in-the-jak-inhibitors-class/2021-10-13T20:16:59+00:00https://globalreachhealth.com/tecentriq-breast-cancer-indication-withdrawn/2021-10-13T20:21:03+00:00https://globalreachhealth.com/global-actemra-shortage-caused-by-covid-19-surge/2021-10-13T20:24:24+00:00https://globalreachhealth.com/high-dose-naloxone-injection-approved-to-treat-opioid-overdose/2021-12-08T19:59:10+00:00https://globalreachhealth.com/seglentis-approved-to-manage-acute-pain/2021-12-08T20:05:22+00:00https://globalreachhealth.com/tyrvaya-becomes-first-fda-approved-nasal-spray-for-dry-eye-disease/2021-12-08T20:09:40+00:00https://globalreachhealth.com/fda-approves-novel-treatment-for-rare-immune-disorder-in-children/2021-12-08T20:16:16+00:00https://globalreachhealth.com/first-new-treatment-in-a-decade-for-anca-vasculitis-approved/2021-12-08T20:20:01+00:00https://globalreachhealth.com/livmarli-becomes-first-fda-approved-drug-for-rare-liver-disease/2021-12-08T20:27:28+00:00https://globalreachhealth.com/qulipta-granted-fda-approval-to-prevent-migraines/2021-12-08T20:31:44+00:00https://globalreachhealth.com/opzelura-cream-approved-to-treat-atopic-dermatitis/2021-12-08T20:35:22+00:00https://globalreachhealth.com/fda-approves-tivdak-for-treatment-of-advanced-cervical-cancer/2021-12-08T20:42:02+00:00https://globalreachhealth.com/comirnaty-authorized-to-prevent-covid-19-in-children-5-11-years-old/2021-12-08T20:45:38+00:00https://globalreachhealth.com/dupixent-asthma-indication-expanded/2021-12-08T20:49:53+00:00https://globalreachhealth.com/vimpat-receives-expanded-indication-to-treat-seizures-in-infants/2021-12-08T20:59:02+00:00https://globalreachhealth.com/fda-expands-covid-19-booster-shot-authorizations/2021-12-08T21:03:40+00:00https://globalreachhealth.com/hiv-treatment-biktarvy-approved-to-treat-younger-children/2021-12-08T21:07:28+00:00https://globalreachhealth.com/tecentriq-granted-new-indication-for-non-small-cell-lung-cancer/2021-12-08T21:11:39+00:00https://globalreachhealth.com/flucelvax-quadrivalent-approved-for-broader-age-group/2021-12-08T21:14:22+00:00https://globalreachhealth.com/verzenio-receives-new-indication-for-high-risk-early-breast-cancer/2021-12-08T21:17:59+00:00https://globalreachhealth.com/dextenza-approved-to-treat-itching-in-the-eye-caused-by-allergies/2021-12-08T21:21:22+00:00https://globalreachhealth.com/tecartus-granted-new-leukemia-indication/2021-12-08T21:25:26+00:00https://globalreachhealth.com/1593-2/2021-12-08T21:32:11+00:00https://globalreachhealth.com/repatha-indicated-to-treat-rare-type-of-high-cholesterol-in-children/2021-12-10T15:42:04+00:00https://globalreachhealth.com/jakafi-now-indicated-to-treat-chronic-graft-vs-host-disease/2021-12-10T15:41:22+00:00https://globalreachhealth.com/merck-recalls-one-lot-of-intravenous-antibiotic/2021-12-10T15:49:02+00:00https://globalreachhealth.com/bryant-ranch-prepack-recalls-mislabeled-muscle-relaxant/2021-12-10T15:55:38+00:00https://globalreachhealth.com/lupin-pharmaceuticals-recalls-all-irbesartan-and-irbesartan-hctz/2021-12-10T15:59:26+00:00https://globalreachhealth.com/teligent-recalls-five-additional-lots-of-lidocaine-topical-solution/2021-12-10T16:14:50+00:00https://globalreachhealth.com/medtronic-expands-class-i-recall-of-insulin-pumps/2021-12-10T16:19:53+00:00https://globalreachhealth.com/bayer-recalls-over-the-counter-anti-fungal-sprays/2021-12-10T16:29:16+00:00https://globalreachhealth.com/eli-lilly-recalls-glucagon-that-may-fail-to-treat-severe-hypoglycemia/2021-12-10T16:39:09+00:00https://globalreachhealth.com/cyltezo-will-be-interchangeable-with-humira-at-the-pharmacy/2021-12-10T16:43:01+00:00https://globalreachhealth.com/eli-lilly-to-reduce-list-prices-for-generic-insulins-in-2022/2021-12-10T16:48:37+00:00https://globalreachhealth.com/voxzogo-becomes-first-in-class-treatment-for-dwarfism/2025-01-23T14:40:32+00:00https://globalreachhealth.com/besremi-approved-for-rare-cancer/2025-01-23T14:50:04+00:00https://globalreachhealth.com/eprontia-approved-for-seizures-and-migraines/2025-01-23T14:50:24+00:00https://globalreachhealth.com/purified-cortrophin-gel-approved/2021-12-10T17:10:24+00:00https://globalreachhealth.com/u-s-fda-approves-vuity-eye-drops-for-presbyopia/2021-12-10T17:14:57+00:00https://globalreachhealth.com/scemblix-approved-to-treat-chronic-myeloid-leukemia/2021-12-10T17:25:53+00:00https://globalreachhealth.com/fda-approves-first-ocular-drug-delivered-by-suprachoroidal-injection/2021-12-10T17:30:54+00:00https://globalreachhealth.com/covid-19-booster-shots-authorized-for-all-adults/2025-01-23T14:40:09+00:00https://globalreachhealth.com/ruxience-approved-to-treat-rheumatoid-arthritis/2025-01-23T14:49:43+00:00https://globalreachhealth.com/mvasi-receives-new-cancer-indication/2025-01-23T14:49:23+00:00https://globalreachhealth.com/dyanavel-xr-approved-in-tablet-form/2025-01-23T14:50:24+00:00https://globalreachhealth.com/cutaquig-indication-now-includes-treatment-of-pediatric-patients/2021-12-10T17:57:12+00:00https://globalreachhealth.com/fda-approves-expanded-indications-for-cyltezo/2021-12-10T18:02:31+00:00https://globalreachhealth.com/new-warning-added-to-climara-pro-prescribing-information/2025-01-23T14:49:01+00:00https://globalreachhealth.com/cdc-may-expand-hepatitis-b-vaccination-recommendations/2021-12-10T18:11:40+00:00https://globalreachhealth.com/cancer-medicine-pepaxto-withdrawn-from-market/2021-12-10T18:16:35+00:00https://globalreachhealth.com/cibinqo-approved-to-treat-atopic-dermatitis/2025-01-23T14:33:31+00:00https://globalreachhealth.com/ryaltris-nasal-spray-approved-for-allergic-rhinitis/2025-01-23T14:33:55+00:00https://globalreachhealth.com/quviviq-receives-approval-to-treat-insomnia/2022-02-08T19:26:59+00:00https://globalreachhealth.com/first-generic-for-cuvposa-launches/2022-02-08T19:30:49+00:00https://globalreachhealth.com/fda-approves-drug-for-hypercortisolemia-in-cushings-syndrome/2022-02-08T19:35:32+00:00https://globalreachhealth.com/adbry-approved-for-atopic-dermatitis/2022-02-08T19:40:17+00:00https://globalreachhealth.com/fda-approves-tascenso-odt-to-treat-multiple-sclerosis-in-children/2022-02-08T19:43:41+00:00https://globalreachhealth.com/leqvio-approved-as-adjunct-therapy-to-lower-cholesterol/2022-02-08T19:46:59+00:00https://globalreachhealth.com/yusimry-approved-as-humira-biosimilar/2022-02-08T19:50:42+00:00https://globalreachhealth.com/first-generic-for-somatuline-depot-approved/2022-02-08T19:57:50+00:00https://globalreachhealth.com/dartisla-odt-approved-to-treat-peptic-ulcer-symptoms/2022-02-08T20:06:16+00:00https://globalreachhealth.com/veklury-use-expanded-in-high-risk-covid-19-patients/2025-01-23T14:27:06+00:00https://globalreachhealth.com/rinvoq-receives-new-atopic-dermatitis-indication/2025-01-23T14:32:55+00:00https://globalreachhealth.com/1694-2/2022-02-08T20:21:20+00:00https://globalreachhealth.com/fda-shortens-moderna-covid-19-vaccine-booster-interval/2022-02-08T20:28:27+00:00https://globalreachhealth.com/rexulti-approved-to-treat-schizophrenia-in-pediatric-patients/2022-02-08T20:33:41+00:00https://globalreachhealth.com/cosentyx-receives-new-and-expanded-pediatric-indications/2022-02-08T20:38:01+00:00https://globalreachhealth.com/vocabria-gains-new-indication-for-hiv-prevention/2022-02-08T21:50:13+00:00https://globalreachhealth.com/caplyta-approved-to-treat-bipolar-depression/2022-02-08T21:54:11+00:00https://globalreachhealth.com/one-batch-of-semglee-recalled-due-to-missing-label/2025-01-23T14:27:25+00:00https://globalreachhealth.com/viona-pharmaceuticals-recalls-metformin-due-to-ndma/2022-02-08T22:05:40+00:00https://globalreachhealth.com/taro-pharmaceuticals-recalls-clobetasol-propionate-ointment/2022-02-08T22:10:51+00:00https://globalreachhealth.com/nitroglycerin-lingual-spray-for-chest-pain-recalled/2022-02-08T22:15:39+00:00https://globalreachhealth.com/new-dental-health-warning-for-some-buprenorphine-products/2025-01-23T14:35:22+00:00https://globalreachhealth.com/updates-to-fact-sheets-for-johnson-johnson-covid-19-vaccine/2025-01-23T14:35:40+00:00https://globalreachhealth.com/fda-releases-report-on-2021-novel-drug-approvals/2022-02-08T22:27:55+00:00https://globalreachhealth.com/brand-medications-with-generic-alternatives-anticipated-tobe-approved-in-february/2025-01-23T14:26:49+00:00https://globalreachhealth.com/avastin-biosimilar-alymsys-granted-approval/2024-04-22T18:16:46+00:00https://globalreachhealth.com/new-acute-treatment-option-for-schizophrenia-and-bipolar-disorder/2022-07-05T08:55:22+00:00https://globalreachhealth.com/vijoice-approved-to-treat-group-of-rare-genetic-disorders/2022-07-05T09:01:34+00:00https://globalreachhealth.com/triumeq-pd-approved-to-treat-hiv/2022-07-05T09:10:25+00:00https://globalreachhealth.com/tlando-offers-new-oral-option-for-testosterone-replacement/2022-07-05T09:15:52+00:00https://globalreachhealth.com/veklury-approved-to-treat-covid-19-in-younger-patient-population/2024-04-22T18:17:20+00:00https://globalreachhealth.com/zerbaxa-now-indicated-for-children/2024-04-22T18:17:09+00:00https://globalreachhealth.com/xigduo-xr-receives-new-indication-for-kidney-disease/2024-04-22T18:16:55+00:00https://globalreachhealth.com/imcivree-approved-in-treatment-of-two-rare-genetic-disorders/2024-04-22T18:17:00+00:00https://globalreachhealth.com/armonair-now-indicated-for-younger-patient-population/2022-07-05T09:45:01+00:00https://globalreachhealth.com/yescarta-granted-approval-for-earlier-use-in-b-cell-lymphoma/2022-07-05T09:48:49+00:00https://globalreachhealth.com/cabenuva-approved-for-children-no-longer-requires-lead-in-therapy/2022-07-05T09:54:19+00:00https://globalreachhealth.com/edurant-and-vocabria-now-approved-for-pediatric-patients/2022-07-05T09:59:05+00:00https://globalreachhealth.com/comirnaty-and-spikevax-authorized-for-second-booster-shots/2022-07-05T10:02:56+00:00https://globalreachhealth.com/higher-ozempic-dose-available-to-improve-blood-sugar-control/2022-07-05T10:07:30+00:00https://globalreachhealth.com/fda-approves-fintepla-use-in-broader-patient-population/2022-07-05T10:22:57+00:00https://globalreachhealth.com/pfizer-recalls-five-lots-of-accupril/2024-04-22T18:17:24+00:00https://globalreachhealth.com/single-batch-of-lantus-generic-recalled/2024-04-22T18:17:04+00:00https://globalreachhealth.com/ardelyx-launches-irritable-bowel-syndrome-treatment-ibsrela/2024-04-22T18:17:15+00:00https://globalreachhealth.com/fda-approves-novel-treatment-for-plaque-psoriasis/2022-08-27T18:33:03+00:00https://globalreachhealth.com/mounjaro-becomes-first-in-class-treatment-for-type-2-diabetes/2022-08-27T18:50:53+00:00https://globalreachhealth.com/fda-approves-new-oral-medication-for-als/2022-08-27T19:02:55+00:00https://globalreachhealth.com/first-therapeutically-equivalent-velcade-generics-approved/2022-08-27T19:07:48+00:00https://globalreachhealth.com/voquezna-approved-to-treat-common-cause-of-stomach-ulcers/2022-08-27T19:12:15+00:00https://globalreachhealth.com/cuvrior-approved-for-life-threatening-genetic-disorder/2022-08-27T19:16:44+00:00https://globalreachhealth.com/first-in-class-treatment-approved-for-hypertrophic-cardiomyopathy/2022-08-27T19:20:19+00:00https://globalreachhealth.com/vivjoa-approved-to-treat-chronic-yeast-infections/2022-08-27T19:25:33+00:00https://globalreachhealth.com/fda-approves-new-benzoyl-peroxide-product-for-rosacea/2022-08-27T19:29:53+00:00https://globalreachhealth.com/kymriah-granted-new-indication-for-follicular-lymphoma/2022-08-27T19:33:28+00:00https://globalreachhealth.com/tibsovo-now-indicated-for-newly-diagnosed-acute-myeloid-leukemia/2022-08-27T19:37:31+00:00https://globalreachhealth.com/vidaza-approved-for-rare-pediatric-blood-cancer/2022-08-27T19:41:44+00:00https://globalreachhealth.com/fda-expands-indication-for-smallpox-treatment/2022-08-27T19:51:30+00:00https://globalreachhealth.com/dupixent-approved-to-treat-eosinophilic-esophagitis/2022-08-27T20:05:24+00:00https://globalreachhealth.com/comirnaty-booster-dose-authorization-expanded/2022-08-27T20:08:17+00:00https://globalreachhealth.com/olumiant-gains-fda-approval-to-treat-covid-19-in-adults/2022-08-27T20:11:39+00:00https://globalreachhealth.com/fda-approves-first-nonstimulant-adhd-drug-for-adults-in-20-years/2022-08-27T20:15:37+00:00https://globalreachhealth.com/rinvoq-now-indicated-for-ankylosing-spondylitis/2022-08-27T20:19:10+00:00https://globalreachhealth.com/ultomiris-granted-new-myasthenia-gravis-indication/2022-08-27T20:22:23+00:00https://globalreachhealth.com/new-caplyta-dosage-strengths-approved/2022-08-27T20:26:17+00:00https://globalreachhealth.com/teva-recalls-one-lot-of-thrombocytopenia-treatment/2022-08-27T20:31:26+00:00https://globalreachhealth.com/esbriet-generic-available-to-treat-rare-lung-disease/2022-08-27T20:35:01+00:00https://globalreachhealth.com/fda-restricts-authorization-of-janssens-covid-19-vaccine/2022-08-27T20:38:28+00:00https://globalreachhealth.com/enhertu-obtains-regular-fda-approval-after-accelerated-approval/2022-08-27T20:41:40+00:00https://globalreachhealth.com/zonisade-approved-to-treat-seizures/2024-04-22T17:57:48+00:00https://globalreachhealth.com/fda-authorizes-additional-covid-19-vaccine/2024-04-22T17:57:37+00:00https://globalreachhealth.com/fda-approves-first-therapy-for-repigmentation-in-vitiligo/2024-04-22T17:57:10+00:00https://globalreachhealth.com/diacomit-approved-for-broader-age-group/2024-04-22T17:57:42+00:00https://globalreachhealth.com/xalkori-granted-new-indication-to-treat-non-cancerous-tumors/2024-04-22T17:57:54+00:00https://globalreachhealth.com/comirnaty-receives-full-fda-approval-for-expanded-age-group/2024-04-22T17:57:26+00:00https://globalreachhealth.com/krystexxa-approved-for-use-with-methotrexate/2024-04-22T17:57:33+00:00https://globalreachhealth.com/pharmacists-now-able-to-prescribe-paxlovid/2022-08-29T20:01:03+00:00https://globalreachhealth.com/fda-updates-evusheld-dosing-recommendations/2022-08-29T20:05:21+00:00https://globalreachhealth.com/qsymia-approved-for-weight-management-in-ages-12-and-up/2022-08-29T20:10:59+00:00https://globalreachhealth.com/mylan-recalls-one-lot-of-insulin-glargine/2024-04-22T17:57:20+00:00https://globalreachhealth.com/zelnorm-withdrawn-from-market/2022-08-29T20:36:52+00:00https://globalreachhealth.com/copiktra-may-increase-risk-for-cancer-patients/2022-08-29T20:40:26+00:00https://globalreachhealth.com/amvuttra-approved-for-rare-genetic-disorder/2022-08-30T15:49:18+00:00https://globalreachhealth.com/fda-approves-priorix-to-prevent-measles-mumps-and-rubella/2022-08-30T15:53:02+00:00https://globalreachhealth.com/fifth-neulasta-biosimilar-approved/2022-08-30T15:57:04+00:00https://globalreachhealth.com/tyvaso-dpi-approved-to-treat-high-blood-pressure-in-the-lungs/2022-08-30T16:00:46+00:00https://globalreachhealth.com/breyanzi-wins-broader-use-in-large-b-cell-lymphoma-treatment/2022-08-30T16:04:24+00:00https://globalreachhealth.com/tafinlar-and-mekinist-approved-to-treat-solid-tumors/2022-08-30T16:07:43+00:00https://globalreachhealth.com/zulresso-indicated-for-postpartum-depression-in-adolescents/2022-08-30T16:14:04+00:00https://globalreachhealth.com/mercks-pneumococcal-vaccine-now-indicated-for-children/2022-08-30T16:18:19+00:00https://globalreachhealth.com/comirnaty-and-spikevax-cleared-for-children-six-months-and-older/2022-08-30T16:22:52+00:00https://globalreachhealth.com/imcivree-approved-to-treat-extreme-hunger-caused-by-rare-disorder/2022-08-30T16:26:25+00:00https://globalreachhealth.com/skyrizi-granted-new-indication-for-crohns-disease/2022-08-30T16:29:51+00:00https://globalreachhealth.com/fda-approves-systemic-treatment-for-alopecia/2022-08-30T16:33:28+00:00https://globalreachhealth.com/lantus-no-longer-restricted-to-type-1-diabetes-in-pediatric-patients/2022-08-30T16:37:10+00:00https://globalreachhealth.com/dupixent-approved-for-eczema-in-young-children/2022-08-30T16:41:24+00:00https://globalreachhealth.com/cellcept-granted-wider-use-in-pediatric-transplant-recipients/2022-08-30T16:44:49+00:00https://globalreachhealth.com/riabni-gains-indication-to-treat-rheumatoid-arthritis/2022-08-30T16:48:47+00:00https://globalreachhealth.com/fda-approves-beovu-to-treat-diabetic-macular-edema/2022-08-30T16:52:09+00:00https://globalreachhealth.com/evrysdi-now-indicated-to-treat-sma-in-patients-of-any-age/2022-08-30T16:56:05+00:00https://globalreachhealth.com/opdivo-gains-new-indications-to-treat-esophageal-cancer/2022-08-30T17:00:51+00:00https://globalreachhealth.com/cancer-drug-ukoniq-withdrawn-from-market-over-safety-concerns/2022-08-30T17:04:49+00:00https://globalreachhealth.com/fda-signs-mutual-recognition-agreement-between-us-and-switzerland/2024-04-22T18:13:07+00:00https://globalreachhealth.com/fda-approves-leqembi-lecanemab-irmb-under-the-accelerated-approvalpathway-for-the-treatment-of-alzheimers-disease/2024-04-22T18:13:23+00:00https://globalreachhealth.com/fda-approves-krazati-adagrasib-for-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-with-a-krasg12c-mutation/2024-04-22T17:57:14+00:00https://globalreachhealth.com/briumvi-ublituximab-xiiy-is-approved-for-the-treatment-of-relapsing-forms-ofmultiple-sclerosis/2024-04-22T18:14:18+00:00https://globalreachhealth.com/nexobrid-anacaulase-bcdb-approved-for-the-treatment-of-severe-thermal-burns-in-adults/2023-02-07T17:36:09+00:00https://globalreachhealth.com/fda-approves-xenoview-xenon-xe-129-hyperpolarized-for-use-with-mri-for-the-evaluation-of-lung-ventilation/2024-04-22T18:14:12+00:00https://globalreachhealth.com/sunlenca-approved-by-fda-for-use-with-other-antiretrovirals-for-the-treatment-of-hiv-1-infections/2023-02-07T17:51:02+00:00https://globalreachhealth.com/lunsumio-approval-from-fda-for-treatment-of-adults-with-relapsed-or-refractory-follicular-lymphoma/2023-02-07T17:56:35+00:00https://globalreachhealth.com/olpruva-receives-fda-approval-for-patients-with-some-urea-cycle-disorders-ucds/2024-04-22T18:14:28+00:00https://globalreachhealth.com/adstiladrin-nadofaragene-firadenovec-vncg-suspension-approved-for-intravesical-use/2023-02-07T18:08:31+00:00https://globalreachhealth.com/iyuzeh-ophthalmic-solution-approved-for-open-angle-glaucoma-and-ocular-hypertension/2023-02-07T18:13:55+00:00https://globalreachhealth.com/newly-approved-indications/2023-02-07T18:21:45+00:00https://globalreachhealth.com/hospira-inc-issues-a-voluntary-nationwide-recall-for-one-lot-of-vancomycin-hydrochloride-injection/2023-02-07T18:29:10+00:00https://globalreachhealth.com/accord-healthcare-inc-issues-nationwide-voluntary-recall-of-daptomycin-for-injection/2023-02-07T18:34:59+00:00https://globalreachhealth.com/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-four-lots-of-quinapril-tablets-due-to-potential-presence-of-n-nitroso-quinapril-impurity/2023-02-07T18:40:28+00:00https://globalreachhealth.com/gfa-production-xiamen-co-ltd-issues-voluntary-nationwide-recall-of-easy-care-first-aid-burn-cream-and-first-aid-kits-due-to-microbial-contamination/2023-02-07T18:57:35+00:00https://globalreachhealth.com/biosimilar-idacio-receives-fda-approval/2023-02-07T19:03:10+00:00https://globalreachhealth.com/occurrence-of-cardiovascular-events-death-compared-between-thiazides/2024-04-22T18:13:18+00:00https://globalreachhealth.com/bebuilder-2001/2024-04-22T18:14:24+00:00https://globalreachhealth.com/methylprednisolone-no-benefit-in-cardiopulmonary-bypass-for-infants/2024-04-22T18:13:12+00:00https://globalreachhealth.com/fda-approves-airsupra-albuterol-budesonide-metered-dose-inhaler-to-reducethe-risk-of-asthma-exacerbations/2023-03-20T18:43:27+00:00https://globalreachhealth.com/fda-has-approved-orserdu-for-the-treatment-of-postmenopausal/2023-03-20T18:44:43+00:00https://globalreachhealth.com/bebuilder-2030/2023-03-20T18:44:20+00:00https://globalreachhealth.com/fda-approves-brenzavvy-bexagliflozin-for-the-treatment-of-adults-with-type-2-diabetes/2023-03-20T18:44:05+00:00https://globalreachhealth.com/fda-approves-rykindo-risperidone-extended-release-injectable-suspension-forthe-treatment-of-schizophrenia-and-bipolar-1-disorder/2023-03-20T18:43:40+00:00https://globalreachhealth.com/fda-approves-jesduvroq-daprodustat-for-anemia-caused-by-chronic-kidney-disease-for-adults-on-dialysis/2023-03-20T18:44:56+00:00https://globalreachhealth.com/fda-approves-trodelvy-sacituzumab-govitecan-hziy-for-patients-with-specific-metastatic-hormone-recepter-breast-cancers-having-received-endocrine-based-therapy-and-at-least-two-additional-therapies/2024-04-22T18:11:39+00:00https://globalreachhealth.com/fda-accelerated-approval-of-tukysa-tucatinib-in-combination-with-trastuzumab-for-peoplewith-previously-treated-ras-wild-type-her2-positive-metastatic-colorectal-cancer/2023-03-20T18:43:53+00:00https://globalreachhealth.com/brukinsa-zanubrutinib-approved-in-the-u-s-for-chronic-lymphocytic-leukemia/2023-03-20T18:49:56+00:00https://globalreachhealth.com/fda-approves-use-of-rybelsus-semaglutide-as-a-first-line-option-for-adults-withtype-2-diabetes/2023-03-20T19:00:54+00:00https://globalreachhealth.com/fda-approves-adacel-for-immunization-during-pregnancy-to-help-protect-younginfants-against-pertussis/2023-03-20T19:08:42+00:00https://globalreachhealth.com/fda-approves-wegovy-as-anti-obesity-medication-for-teens-with-once-weekly-dosing/2023-03-20T20:40:24+00:00https://globalreachhealth.com/fda-approves-tymlos-as-a-treatment-to-increase-bone-density-in-men-withosteoporosis-at-high-risk-for-fracture/2023-03-20T20:48:28+00:00https://globalreachhealth.com/fda-approves-vraylar-cariprazine-as-an-adjunctive-treatment-for-majordepressive-disorder/2023-03-20T20:53:23+00:00https://globalreachhealth.com/fda-approves-indication-for-pemfexy-in-combination-with-pembrolizumab-andplatinum-chemotherapy/2023-03-20T21:00:17+00:00https://globalreachhealth.com/adma-biologics-announces-fda-approval-for-room-temperature-storage-of-asceniv-bivigam/2023-03-20T21:05:11+00:00https://globalreachhealth.com/fda-approves-monday-wednesday-friday-intramuscular-dosing-schedule-forrylaze-asparaginase-erwinia-chrysanthemi-recombinant-rywn/2023-03-20T21:09:24+00:00https://globalreachhealth.com/global-pharma-healthcare-issues-voluntary-nationwide-recall-of-artificial-tears-lubricant-eye-drops-due-to-possible-contamination/2024-04-22T18:11:53+00:00https://globalreachhealth.com/smiths-medical-recalls-certain-cadd-system-administration-sets-and-cassette-reservoirs-for-issues-causing-delay-interruption-or-under-delivery-of-therapy/2024-04-22T18:11:47+00:00https://globalreachhealth.com/shop-me-ca-recalls-diep-bao-cream-because-of-possible-health-risk/2024-04-22T18:12:10+00:00https://globalreachhealth.com/ibsa-pharma-inc-issues-voluntary-nationwide-recall-of-select-lots-oftirosint-sol-levothyroxine-sodium-oral-solution-due-to-subpotency/2024-04-22T18:12:05+00:00https://globalreachhealth.com/other-news-and-announcements/2024-04-22T18:11:42+00:00https://globalreachhealth.com/new-guidance-for-industry-m13a-bioequivalence-for-immediate-release-solid-oral-dosage-forms/2023-03-20T22:37:56+00:00https://globalreachhealth.com/fda-aims-to-simplify-vaccination-with-tweaks-to-long-term-covid-19-strategy/2024-04-22T18:12:00+00:00https://globalreachhealth.com/savings-opportunities-with-upcoming-specialty-and-traditional-generics/2023-03-20T22:58:19+00:00https://globalreachhealth.com/brand-medications-with-generic-alternatives-approved-indecember-2022/2023-03-20T23:11:12+00:00https://globalreachhealth.com/pt-committee-changes/2024-04-22T18:09:52+00:00https://globalreachhealth.com/new-drug-approvals/2023-06-12T20:07:42+00:00https://globalreachhealth.com/altuviiio/2023-06-10T19:45:16+00:00https://globalreachhealth.com/syfovre/2023-06-10T19:52:45+00:00https://globalreachhealth.com/lamzede/2023-06-10T19:58:08+00:00https://globalreachhealth.com/filspari/2023-06-10T20:06:35+00:00https://globalreachhealth.com/zavzpret/2023-06-10T20:16:50+00:00https://globalreachhealth.com/global-pharma-healthcare-issues-voluntary-nationwide/2023-06-10T20:25:33+00:00https://globalreachhealth.com/pharmedica-usa-llc-issues-voluntary-worldwide/2023-06-11T02:30:07+00:00https://globalreachhealth.com/researchers-announce-highly-accurate-blood-test-for-alzheimers-disease/2023-06-11T02:38:58+00:00https://globalreachhealth.com/pfizers-elranatamab-receives-fda-and-ema-filing-acceptance/2023-06-11T02:42:39+00:00https://globalreachhealth.com/pozelimab-c5-antibody-bla-for-treatment-of-children-and-adults/2023-06-11T02:48:19+00:00https://globalreachhealth.com/rezvoglar-price-announced/2023-06-11T03:01:02+00:00https://globalreachhealth.com/fda-approves-zynyz-for-the-treatment-of-metastatic/2023-06-11T03:07:05+00:00https://globalreachhealth.com/inflarx-receives-fda-emergency-use-authorization-for-gohibic/2023-06-11T03:14:34+00:00https://globalreachhealth.com/fda-approves-joenja/2023-06-11T03:19:33+00:00https://globalreachhealth.com/fda-approves-daybue-trofinetide-for-the-treatment-of-rettsyndrome/2023-06-11T03:24:12+00:00https://globalreachhealth.com/fda-approves-rezzayo-for-the-treatment-ofcandidemia-and-invasive-candidiasis/2023-06-11T03:28:52+00:00https://globalreachhealth.com/newly-approved-indications-2/2023-06-11T03:32:42+00:00https://globalreachhealth.com/fda-commissioner-and-chief-scientist-announce-decision-towithdraw-approval-of-makena/2023-06-11T03:42:04+00:00https://globalreachhealth.com/ascend-laboratories-llc-issues-voluntary-nationwide-recall-of-dabigatran-etexilate-capsules/2023-06-11T03:59:11+00:00https://globalreachhealth.com/fda-issues-draft-guidance-on-patient-focused-drug-development/2023-06-11T04:04:07+00:00https://globalreachhealth.com/update-on-insulin-prices-and-pipeline-products/2023-06-11T05:48:09+00:00https://globalreachhealth.com/fda-research-examines-pharmacodynamic-biomarkers-in-biosimilardevelopment/2023-06-11T05:58:25+00:00https://globalreachhealth.com/fda-adds-quinacrine-hydrochloride-quinacrine/2023-06-11T06:06:05+00:00https://globalreachhealth.com/novartis-announces-positive-topline-results-for-kisquali-as-adjuvanttreatment-for-early-breast-cancer/2023-06-11T06:13:17+00:00https://globalreachhealth.com/fda-clarifies-pharmacist-recommendations-in-buprenorphine-foropioid-dependence-rems/2023-06-11T06:16:35+00:00https://globalreachhealth.com/fda-approves-arexvy-respiratory-syncytial-virus-vaccine-for-older-adults/2023-06-12T20:05:32+00:00https://globalreachhealth.com/fda-approves-lumryz-for-cataplexy-or-excessive/2023-06-11T17:53:20+00:00https://globalreachhealth.com/fda-approves-omisirge-cell-therapy-for-patients-with-blood-cancers/2023-06-11T17:58:52+00:00https://globalreachhealth.com/fda-grants-accelerated-approval-for-qalsody-for-the-treatment-of-amyotrophic-lateral-sclerosis-associated/2023-06-11T18:04:23+00:00https://globalreachhealth.com/fda-approval-of-vowst-for-cdi-recurrence/2023-06-11T18:08:35+00:00https://globalreachhealth.com/fda-approval-of-vowst-for-cdi-recurrence-2/2023-06-12T15:12:17+00:00https://globalreachhealth.com/fda-approves-abilify-asimtufii-for-the-treatment-of-schizophrenia-or-maintenance-monotherapy-treatment/2023-06-12T15:25:33+00:00https://globalreachhealth.com/uzedy-extended-release-injectable-approved-by-fda-for-treatment-ofschizophrenia/2023-06-12T15:30:32+00:00https://globalreachhealth.com/fda-approves-rizafilm-oral-film-for-the-treatment-of-acute-migraine/2023-06-12T15:48:11+00:00https://globalreachhealth.com/fda-approves-first-over-the-counter-naloxone-nasal-spray/2023-06-12T15:53:19+00:00https://globalreachhealth.com/teva-initiates-voluntary-nationwide-recall-of-specific-lots-of-fentanylbuccal-tablets-cii-due-to-a-labeling-error/2023-06-12T16:02:44+00:00https://globalreachhealth.com/akorn-issues-voluntary-nationwide-recall-of-various-human-and-animal-drug-products-within-expiry-due-to-company-shutdown/2023-06-12T16:14:42+00:00https://globalreachhealth.com/camber-pharmaceuticals-issues-voluntary-nationwide-recall-of-atovaquone-oral-suspension/2023-06-12T17:17:49+00:00https://globalreachhealth.com/ascend-laboratories-llc-issues-voluntary-nationwide-recall-of-dabigatran-etexilate-capsules-2/2023-06-12T17:35:16+00:00https://globalreachhealth.com/sd-biosensor-inc-requests-discontinuation-of-use-and-disposal-of-specific-pilot-covid-19/2023-06-12T18:47:19+00:00https://globalreachhealth.com/radiologists-group-pushes-for-breast-cancer-risk-assessment-by-age-25/2024-04-22T18:08:43+00:00https://globalreachhealth.com/u-s-death-rate-declined-in-2022-covid-deaths-fell-by-almost-half/2024-04-22T18:08:49+00:00https://globalreachhealth.com/cedars-sinai-develops-ai-to-predict-adverse-cardiac-events/2023-06-12T20:04:03+00:00https://globalreachhealth.com/upcoming-formulary-changes/2024-04-22T18:06:40+00:00https://globalreachhealth.com/p-and-t-committee-changes-2/2024-04-22T18:06:37+00:00https://globalreachhealth.com/new-drug-approvals-fda-approves-opvee/2023-06-26T17:58:50+00:00https://globalreachhealth.com/fda-approves-epkinly/2023-06-27T03:57:34+00:00https://globalreachhealth.com/abryvso/2024-04-22T18:07:11+00:00https://globalreachhealth.com/miebo/2023-06-27T04:15:17+00:00https://globalreachhealth.com/fda-approves-xacduro-for-the-treatment-of-serious-infections-caused-by-acinetobacter/2023-06-27T04:45:03+00:00https://globalreachhealth.com/fda-approves-brixadi-extended-release-subcutaneous-injection-for-moderate-tosevere-opioid-use-disorder/2023-06-27T13:38:51+00:00https://globalreachhealth.com/fda-approves-novel-drug-to-treat-moderate-to-severe-hot-flashes-caused-by-menopause/2023-06-27T13:46:34+00:00https://globalreachhealth.com/fda-approves-inpefa-sotagliflozin-for-the-treatment-of-heart-failure/2023-06-27T13:52:52+00:00https://globalreachhealth.com/fda-approves-paxlovid-nirmatrelvir-tablets-and-ritonavir-tablets-for-adult-patients-at-high-risk-ofprogression-to-severe-covid-19/2023-06-27T13:58:44+00:00https://globalreachhealth.com/fda-approves-posluma-flotufolastat-f-18-injection-first-radiohybrid-psma-targeted-pet-imagingagent-for-prostate-cancer/2024-04-22T18:07:17+00:00https://globalreachhealth.com/fda-approves-vyjuvek-beremagene-geperpavec-svdt-redosable-gene-therapy-for-thetreatment-of-dystrophic-epidermolysis-bullosa/2023-06-27T14:13:24+00:00https://globalreachhealth.com/fda-approves-elfabrio-pegunigalsidase-alfa-iwxj-for-the-treatment-of-adult-patients-with-fabrydisease/2023-06-27T14:17:24+00:00https://globalreachhealth.com/fda-approves-mydcombi-tropicamide-and-phenylephrine-hydrochloride-ophthalmic-spray-forinducing-mydriasis/2023-06-27T14:21:57+00:00https://globalreachhealth.com/fda-approves-lynparza-olaparib-plus-abiraterone-and-prednisone-or-prednisolone-for-treatment-ofadult-patients-with-brca-mutated-metastatic-castration-resistant-prostate-cancer-mcrpc/2024-04-22T18:07:05+00:00https://globalreachhealth.com/coherus-biosciences-announced-plans-to-launch-yusimry-its-humira-biosimilar/2024-04-22T18:06:58+00:00https://globalreachhealth.com/fda-approves-yuflyma-adalimumab-aaty-a-biosimilar-to-humira/2023-06-27T14:40:00+00:00https://globalreachhealth.com/adverse-events-can-be-reported-to-the-fdas-medwatch-program/2024-04-22T18:06:51+00:00https://globalreachhealth.com/researchers-explore-ozempic-as-a-potential-addiction-treatment/2024-04-22T18:06:47+00:00https://globalreachhealth.com/fda-approves-roctavian-valoctocogene-roxaparvovec-rvox-gene-therapy-for-adults-with-severehemophilia-a/2025-01-23T13:56:58+00:00https://globalreachhealth.com/fda-approves-lantidra-donislecel-jujn-cellular-therapy-to-treat-patients-with-type-1-diabetes/2025-01-23T14:04:10+00:00https://globalreachhealth.com/fda-approves-ngenla-somatrogon-ghla-long-acting-once-weekly-treatment-for-pediatric-growthhormone-deficiency/2025-01-23T13:57:00+00:00https://globalreachhealth.com/fda-approves-rystiggo-rozanolixizumab-noli-for-the-treatment-of-adults-with-generalizedmyasthenia-gravis/2025-01-23T14:04:10+00:00https://globalreachhealth.com/fda-approves-litfulo-ritlecitinib-for-adults-and-adolescents-with-severe-alopecia-areata/2025-01-23T14:00:38+00:00https://globalreachhealth.com/fda-approves-elevidys-delandistrogene-moxeparvovec-rokl-gene-therapy-to-treat-duchennemuscular-dystrophy/2023-08-23T14:22:06+00:00https://globalreachhealth.com/fda-approves-vyvgart-hytrulo-efgartigimod-alfa-and-hyaluronidase-qvfc-for-subcutaneous-use-ingeneralized-myasthenia-gravis/2023-08-23T14:27:26+00:00https://globalreachhealth.com/fda-approves-lodoco-colchicine-as-the-first-anti-inflammatory-drug-for-cardiovascular-disease/2023-08-23T14:31:40+00:00https://globalreachhealth.com/fda-approves-columvi-glofitamab-gxbm-bispecific-antibody-for-the-treatment-of-relapsed-orrefractory-diffuse-large-b-cell-lymphoma/2023-08-23T14:37:14+00:00https://globalreachhealth.com/fda-approves-suflave-polyethylene-glycol-3350-sodium-sulfate-potassium-chloride-magnesiumsulfate-and-sodium-chloride-colonoscopy-preparation-that-tastes-similar-to-a-sports-drink/2023-08-23T14:41:56+00:00https://globalreachhealth.com/fda-approves-vevye-cyclosporine-ophthalmic-solution-for-the-treatment-of-the-signs-andsymptoms-of-dry-eye-disease/2023-08-23T14:48:22+00:00https://globalreachhealth.com/fda-grants-full-approval-for-blincyto-blinatumomab-to-treat-minimal-residualdisease-positive-b-cell-precursor-acute-lymphoblastic-leukemia/2023-08-23T14:53:25+00:00https://globalreachhealth.com/us-fda-approves-the-cyltezo-pen-a-new-autoinjector-option/2023-08-23T15:11:39+00:00https://globalreachhealth.com/cipla-issues-voluntary-nationwide-recall-of-six-batches-of-albuterol-sulfateinhalation-aerosol-90-mcg-200-metered-inhalation-due-to-container-defect/2025-01-23T13:54:43+00:00https://globalreachhealth.com/the-harvard-drug-group-llc-issues-voluntary-nationwide-recall-of-dronabinolcapsules-usp-2-5-mg-and-ziprasidone-hydrochloride-capsules-20-mg-due-to-labelmix-up/2023-08-23T15:54:59+00:00https://globalreachhealth.com/in-study-almost-half-of-obese-teens-were-no-longer-so-after-takingwegovy-ozempic/2025-01-23T13:54:01+00:00https://globalreachhealth.com/fda-grants-leqembi-full-approval-for-alzheimers-care/2025-01-23T13:50:43+00:00https://globalreachhealth.com/standard-clinical-review-list/2023-09-04T19:21:03+00:00https://globalreachhealth.com/drug-quantity-management-program/2023-09-04T20:02:15+00:00https://globalreachhealth.com/specialty-clinical-consultation-list/2023-09-04T21:14:56+00:00https://globalreachhealth.com/performance-formulary-step-therapy/2023-09-04T21:38:03+00:00https://globalreachhealth.com/primary-formulary-step-therapy/2023-09-04T21:53:45+00:00https://globalreachhealth.com/responsiblerx-medications-with-lower-cost-brand-alternatives/2023-09-05T19:38:21+00:00https://globalreachhealth.com/pt-committee-changes-2/2023-09-05T19:35:26+00:00https://globalreachhealth.com/performance-formulary-changes/2023-09-05T19:48:56+00:00https://globalreachhealth.com/primary-formulary-changes-2/2023-09-05T19:47:54+00:00https://globalreachhealth.com/fda-approves-aphexda-motixafortide-to-mobilize-hematopoieticstem-cells-for-autologous-transplantation-in-patients-with-multiplemyeloma/2023-10-24T17:23:10+00:00https://globalreachhealth.com/fda-approves-first-biosimilar-to-treat-multiple-sclerosis/2023-10-24T17:29:56+00:00https://globalreachhealth.com/regeneron-wins-fda-approval-for-rare-immune/2023-10-24T17:35:17+00:00https://globalreachhealth.com/fda-approves-eylea-hd-aflibercept-injection-8mg-for-treatment-of-wetage-related-macular-degeneration-wamd-diabetic-macular-edemadme-and-diabetic-retinopathy-dr/2023-10-24T17:44:21+00:00https://globalreachhealth.com/fda-approves-sohonos-palovarotene-for-the-treatment-of-fibrodysplasia-ossificans-progressiva/2023-10-24T17:49:16+00:00https://globalreachhealth.com/fda-grants-accelerated-approval-for-elrexfio-elranatamab-bcmm-for-relapsed-or-refractory-multiple-myeloma/2023-10-24T17:54:47+00:00https://globalreachhealth.com/fda-approves-hepzato-kit-melphalan-hepatic-delivery-system-for-the-treatment-of-unresectable-hepatic-dominant-metastatic-uveal-melanoma/2023-10-24T18:36:26+00:00https://globalreachhealth.com/pfizer-and-biontech-receive-u-s-fda-approval-for-2023-2024-covid-19-vaccine/2023-10-24T18:43:16+00:00https://globalreachhealth.com/first-line-treatment-of-metastatic-castration-resistant-prostate-cancer/2023-10-24T18:50:23+00:00https://globalreachhealth.com/fda-approves-first-therapeutic-indication-for-revances-daxxify-daxibotulinumtoxina-lanm-for-injection-for-the-treatment-of-cervical-dystonia/2023-10-24T18:54:54+00:00https://globalreachhealth.com/novartis-issues-voluntary-nationwide-recall-of-one-lot-of-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mg-ml-due-to-crystallization/2023-10-24T19:06:23+00:00https://globalreachhealth.com/fda-issues-warning-letters-to-firms-marketing-unapproved-eye-products/2023-10-24T19:16:49+00:00https://globalreachhealth.com/upcoming-formulary-changes-2/2023-10-24T20:16:29+00:00https://globalreachhealth.com/fda-approves-rivfloza-nedosiran-for-the-treatment-of-primary-hyperoxaluria-type-1-ph1/2023-11-16T14:31:26+00:00https://globalreachhealth.com/fda-approves-technegas-technetium-tc-99-m-labeled-carbon-radioactive-diagnostic-agent/2023-11-16T14:38:27+00:00https://globalreachhealth.com/fda-approves-ojjaara-momelotinib-for-myelofibrosis-patients-with-anemia/2023-11-16T14:44:32+00:00https://globalreachhealth.com/fda-approves-exxua-gepirone-for-the-treatment-of-major-depressive-disorder-in-adults/2023-11-16T14:54:30+00:00https://globalreachhealth.com/fda-approves-likmez-metronidazole-oral-suspension-for-the-treatment-of-parasitic-and-anaerobic-bacterial-infections/2023-11-16T15:00:45+00:00https://globalreachhealth.com/fda-approves-ryzumvi-phentolamine-ophthalmic-solution-for-the-treatment-of-pharmacologically-induced-mydriasis/2023-11-16T15:05:50+00:00https://globalreachhealth.com/fda-approves-pombiliti-cipaglucosidase-alfa-atga-opfolda-miglustat-for-the-treatment-of-late-onset-pompe-disease/2023-11-16T15:24:57+00:00https://globalreachhealth.com/fda-grants-accelerated-approval-for-elrexfio-elranatamab-bcmm-for-relapsed-or-refractory-multiple-myeloma-2/2023-11-16T15:29:22+00:00https://globalreachhealth.com/fda-approves-tofidence-tocilizumab-bavi-a-biosimilar-to-actemra/2023-11-16T15:33:49+00:00https://globalreachhealth.com/hospira-inc-issues-a-voluntary-nationwide-recall-for-4-2-sodium-bicarbonate-injection-usp-and-1-and-2-lidocaine-hcl-injection-usp-due-to-the-potential-for-presence-of-glass-particulate-matter/2023-11-16T15:53:59+00:00https://globalreachhealth.com/scynexis-issues-a-voluntary-nationwide-recall-of-brexafemme-ibrexafungerp-tablets-due-to-potential-for-cross-contamination-with-a-non-antibacterial-slactam-drug-substance/2023-11-16T16:01:39+00:00https://globalreachhealth.com/kvk-tech-inc-issues-voluntary-nationwide-recall-of-one-lot-of-betaxolol-tablets-usp-10-mg-batch-number-17853a-as-a-precautionary-measure-due-to-a-single-foreign-tablet/2023-11-16T16:18:44+00:00https://globalreachhealth.com/standard-clinical-review-list-2/2023-11-16T22:20:33+00:00https://globalreachhealth.com/drug-quantity-management-program-2/2023-11-16T22:16:48+00:00https://globalreachhealth.com/pt-committee-changes-3/2023-11-16T22:18:05+00:00https://globalreachhealth.com/specialty-clinical-consultation-list-2/2023-11-16T21:32:48+00:00https://globalreachhealth.com/primary-formulary-step-therapy-2/2023-11-16T22:07:37+00:00https://globalreachhealth.com/fda-approves-ixchiq-chikungunya-vaccine-live-for-the-prevention-of-disease-caused-by-chikungunya-virus/2023-11-22T13:46:28+00:00https://globalreachhealth.com/fda-approves-zepbound-for-chronic-weight-management-a-new-treatment-of-obesity-or-overweight-with-weight-related-medical-problems/2023-11-22T13:51:44+00:00https://globalreachhealth.com/fda-approves-fruzaqla-fruquintinib-for-previously-treated-metastatic-colorectal-cancer/2023-11-22T13:56:44+00:00https://globalreachhealth.com/fda-approves-zituvimet-sitagliptin-and-metformin-hydrochloride-to-treat-adult-patients-with-type-2-diabetes-mellitus/2023-11-22T14:00:57+00:00https://globalreachhealth.com/fda-approves-voquezna-vonoprazan-for-the-treatment-of-erosive-gerd-and-relief-of-heartburn-associated-with-erosive-gerd-in-adults/2023-11-22T14:06:19+00:00https://globalreachhealth.com/fda-approves-loqtorzi-toripalimab-tpzi-in-all-lines-of-treatment-for-recurrent-or-metastatic-nasopharyngeal-carcinoma-npc/2023-11-22T14:14:30+00:00https://globalreachhealth.com/fda-approves-omvoh-mirikizumab-mrkz-a-first-in-class-treatment-for-adults-with-moderately-to-severely-active-ulcerative-colitis/2023-11-22T14:21:13+00:00https://globalreachhealth.com/fda-approves-agamree-vamorolone-for-the-treatment-of-duchenne-muscular-dystrophy/2023-11-22T14:27:30+00:00https://globalreachhealth.com/fda-approves-zymfentra-infliximab-dyyb-subcutaneous-formulation-for-the-treatment-of-people-with-inflammatory-bowel-disease/2023-11-22T14:38:38+00:00https://globalreachhealth.com/fda-approves-cabtreo-clindamycin-phosphate-adapalene-and-benzoyl-peroxide-topical-gel-for-the-treatment-of-acne-vulgaris/2023-11-22T15:52:41+00:00https://globalreachhealth.com/fda-approves-zituvio-sitagliptin-for-the-treatment-of-adult-patients-with-type-2-diabetes-mellitus/2023-11-22T15:58:30+00:00https://globalreachhealth.com/fda-approves-penbraya-meningococcal-groups-a-b-c-w-and-y-vaccine-for-the-prevention-of-the-five-most-common-serogroups-causing-meningococcal-disease-in-adolescents/2023-11-22T16:04:00+00:00https://globalreachhealth.com/fda-approves-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia/2023-11-22T16:08:47+00:00https://globalreachhealth.com/fda-approves-maxigesic-iv-to-be-marketed-in-the-u-s-as-combogesic-iv-acetaminophen-and-ibuprofen-for-the-management-of-pain/2023-11-22T16:13:20+00:00https://globalreachhealth.com/fda-approves-bimzelx-bimekizumab-bkzx-for-the-treatment-of-adults-with-moderate-to-severe-plaque-psoriasis/2023-11-22T16:17:15+00:00https://globalreachhealth.com/fda-approves-zilbrysq-zilucoplan-for-the-treatment-of-adults-with-generalized-myasthenia-gravis/2023-11-22T16:21:23+00:00https://globalreachhealth.com/fda-approves-xphozah-tenapanor-to-reduce-serum-phosphorus-in-adults-with-chronic-kidney-disease/2023-11-22T16:25:07+00:00https://globalreachhealth.com/fda-approves-velsipity-for-moderate-to-severe-ulcerative-colitis-in-adults/2023-11-22T16:28:41+00:00https://globalreachhealth.com/fda-approval-for-generic-to-votrient/2023-11-22T16:32:54+00:00https://globalreachhealth.com/fda-approves-wezlana-ustekinumab-auub-an-interchangeable-biosimilar-to-stelara/2023-11-22T16:41:03+00:00https://globalreachhealth.com/botanical-be-issues-voluntary-nationwide-recall-of-kuka-flex-forte-artri-king-and-reumo-flex-capsules-due-to-presence-of-undeclared-diclofenac/2023-11-22T16:49:23+00:00https://globalreachhealth.com/exela-issues-voluntary-nationwide-recall-of-sodium-bicarbonate-8-4-midazolam-in-0-8-sodium-chloride-and-elcys-injections-due-to-presence-of-particulate-matter/2023-11-22T17:17:07+00:00https://globalreachhealth.com/important-information-about-the-correct-dosage-and-administration-of-moderna-covid-19-vaccine-2023-2024-formula-for-individuals-6-months-through-11-years-of-age/2023-11-22T17:24:54+00:00https://globalreachhealth.com/earlier-onset-of-a-fib-linked-to-risk-of-developing-all-cause-dementia/2023-11-22T17:31:32+00:00https://globalreachhealth.com/opioid-use-down-with-erector-spinae-plane-blocks-in-lumbar-laminectomy/2023-11-22T18:29:33+00:00https://globalreachhealth.com/prescription-benefit-coverage-recommended-as-preventive-care-benefits/2023-11-22T18:58:44+00:00https://globalreachhealth.com/fda-approves-eohilia-budesonide-oral-suspension-for-the-treatment-of-eosinophilic-esophagitis/2024-03-05T17:27:46+00:00https://globalreachhealth.com/ipsens-onivyde-regimen-a-potential-new-standard-of-care-first-line-therapy-in-metastatic-pancreatic-adenocarcinoma-mpdac-approved-by-the-fda/2024-03-05T19:17:11+00:00https://globalreachhealth.com/generic-drug-approvals-emflaza/2024-03-05T17:50:08+00:00https://globalreachhealth.com/generic-drug-approvals-bromfenac/2024-03-05T18:06:18+00:00https://globalreachhealth.com/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall/2024-03-05T19:31:05+00:00https://globalreachhealth.com/scientists-develop-sensor-that-tests-saliva-for-breast-cancer/2024-03-05T19:29:43+00:00https://globalreachhealth.com/cdc-may-consider-loosening-covid-isolation-guidance/2024-03-05T19:56:43+00:00https://globalreachhealth.com/fda-grants-accelerated-approval-for-tecelra-cell-therapy-for-the-treatment-of-synovial-sarcoma/2024-08-12T19:12:37+00:00https://globalreachhealth.com/fda-approves-zunveyl-for-the-treatment-of-alzheimers-disease/2024-08-12T19:23:19+00:00https://globalreachhealth.com/fda-approves-erzofri-for-the-treatment-of-schizophrenia-and-schizoaffective-disorder/2024-08-12T19:32:10+00:00https://globalreachhealth.com/fda-approves-leqselvi-an-oral-jak-inhibitor-for-the-treatment-of-severe-alopecia-areata/2024-08-12T19:39:48+00:00https://globalreachhealth.com/fda-approves-femlyv-orally-disintegrating-birth-control-pill/2024-08-12T19:46:41+00:00https://globalreachhealth.com/fda-approves-epysqli-a-biosimilar-to-soliris/2024-08-12T19:55:37+00:00https://globalreachhealth.com/generic-drug-approvals-july-2024/2024-08-12T20:18:00+00:00https://globalreachhealth.com/endo-usa-inc-issues-recall-of-one-lot-of-clonazepam-orally-disintegrating-tablets-due-to-mislabeling-incorrect-strength-on-product-carton/2024-08-12T21:27:34+00:00https://globalreachhealth.com/main-products-inc-issues-recall-of-umary-acido-hialuronico-suplemento-alimenticio-due-to-the-presence-of-undeclared-drug-ingredients/2024-08-12T21:25:13+00:00https://globalreachhealth.com/other-announcements-and-articles/2024-08-12T20:54:58+00:00https://globalreachhealth.com/fda-warns-against-purchasing-or-using-chemical-peel-skin-products-without-professional-supervision/2024-08-12T21:22:59+00:00https://globalreachhealth.com/fda-approves-flyrcado-radioactive-diagnostic-for-enhanced-diagnosis-of-coronaryartery-disease/2024-10-27T18:45:26+00:00https://globalreachhealth.com/fda-approves-cobenfy-a-first-in-class-muscarinic-agonist-for-the-treatment-ofschizophrenia-in-adults/2024-10-27T18:59:17+00:00https://globalreachhealth.com/fda-approves-aqneursa-for-the-treatment-of-niemann-pick-disease-type-c/2024-10-27T19:07:44+00:00https://globalreachhealth.com/fda-approves-miplyffa-for-the-treatment-of-niemann-pick-disease-type-c/2024-10-27T19:26:28+00:00https://globalreachhealth.com/fda-approves-ebglyss-for-the-treatment-of-atopic-dermatitis/2024-10-27T19:31:35+00:00https://globalreachhealth.com/fda-approves-ocrevus-zunovo-a-twice-a-year-subcutaneous-injection-for-peoplewith-relapsing-and-progressive-multiple-sclerosis/2024-10-27T19:38:41+00:00https://globalreachhealth.com/fda-approves-tecentriq-hybreza-anti-pd-l1-cancer-immunotherapy/2024-10-27T19:49:03+00:00https://globalreachhealth.com/fda-approves-boruzu-ready-to-use-injection-for-multiple-myeloma-and-mantlecell-lymphoma/2024-10-27T19:56:45+00:00https://globalreachhealth.com/fda-approves-otulfi-a-biosimilar-to-stelara/2024-10-27T20:06:42+00:00https://globalreachhealth.com/generic-drug-approvals/2024-10-27T20:40:05+00:00https://globalreachhealth.com/fda-is-alerting-patients-and-health-care-professionals-about-the-voluntary-withdrawal-of-oxbryta-from-the-market-due-to-safety-concerns/2024-10-27T20:47:20+00:00https://globalreachhealth.com/gilead-issues-voluntary-nationwide-recall-of-one-lot-of-veklury-remdesivir-for-injection-100mg-vial-due-to-the-presence-of-a-glass-particle/2024-10-27T21:13:48+00:00https://globalreachhealth.com/bionpharma-inc-issues-voluntary-nationwide-recall-of-atovaquone-oral-suspension-due-to-bacterial-contamination/2024-10-27T21:11:28+00:00https://globalreachhealth.com/other-announcements-and-articles-2/2024-10-27T21:39:56+00:00